Viewport Size Code:
Login | Create New Account
picture

  MENU

About | Classical Genetics | Timelines | What's New | What's Hot

About | Classical Genetics | Timelines | What's New | What's Hot

icon

Bibliography Options Menu

icon
QUERY RUN:
HITS:
PAGE OPTIONS:
Hide Abstracts   |   Hide Additional Links
NOTE:
Long bibliographies are displayed in blocks of 100 citations at a time. At the end of each block there is an option to load the next block.

Bibliography on: Microbiome

The Electronic Scholarly Publishing Project: Providing world-wide, free access to classic scientific papers and other scholarly materials, since 1993.

More About:  ESP | OUR CONTENT | THIS WEBSITE | WHAT'S NEW | WHAT'S HOT

ESP: PubMed Auto Bibliography 06 Sep 2026 at 01:53 Created: 

Microbiome

It has long been known that every multicellular organism coexists with large prokaryotic ecosystems — microbiomes — that completely cover its surfaces, external and internal. Recent studies have shown that these associated microbiomes are not mere contamination, but instead have profound effects upon the function and fitness of the multicellular organism. We now know that all MCEs are actually functional composites, holobionts, composed of more prokaryotic cells than eukaryotic cells and expressing more prokaryotic genes than eukaryotic genes. A full understanding of the biology of "individual" eukaryotes will now depend on an understanding of their associated microbiomes.

Created with PubMed® Query: microbiome[tiab] NOT pmcbook NOT ispreviousversion

Citations The Papers (from PubMed®)

-->

RevDate: 2026-09-04

Wu Q, Li L, Lei Y, et al (2026)

Discovering repurposable drugs for Alzheimer's disease and related dementias: target trial emulation using decentralised real-world data.

EBioMedicine, 132:106466 pii:S2352-3964(26)00350-6 [Epub ahead of print].

BACKGROUND: Alzheimer's disease and related dementias (ADRD) affect nearly 6.9 million Americans, with the number expected to triple by 2050, while disease-modifying therapies remain unavailable. Drug repurposing, which identifies new indications for already approved medications, offers a more efficient and cost-effective pathway to accelerate development of effective therapies for ADRD. The aim of this study is to identify potential drug repurposing signals by systematically screening routinely prescribed drugs for associations with progression from mild cognitive impairment (MCI) to ADRD.

METHODS: We conducted a multi-site target trial emulation using electronic health record (EHR) data from four decentralised databases: INSIGHT Clinical Research Network, OneFlorida + Clinical Research Consortium, the University of Pennsylvania Health System, and Yale New Haven Health System. We performed an independent validation using EHR data from the TriNetX Research Network and a genetic risk-stratified sensitivity analysis in the Penn Medicine BioBank (PMBB) database. Eligible participants were adults aged 50 years or older at the time of MCI diagnosis, with no prior diagnosis of ADRD and no prior use of the trial drugs. Initiation of each of 181 routinely prescribed drugs was compared with two active control groups defined by initiation of supplements or cardiovascular medications. Risk ratios (RRs) and 95% CIs were estimated using a federated target trial emulation framework (LATTE) with stabilised inverse probability of treatment weighting and Poisson regression.

FINDINGS: A total of 122,972 eligible patients were identified from the four decentralised databases, 335,506 patients identified from the TriNetX network for validation and 898 from PMBB database. Federated, multi-site target trial emulation identified 20 drug repurposing hypotheses with statistically significant protective effects, including anti-inflammatory and pain-modulating agents (celecoxib: RR 0.43; 95% CI: 0.23-0.81; dexamethasone RR 0.46; 95% CI: 0.29-0.73; gabapentin: RR 0.55; 95% CI: 0.36-0.83; ketorolac: RR 0.50; 95% CI: 0.31-0.80; methylprednisolone: RR 0.43; 95% CI: 0.24-0.76; prednisone: RR 0.48; 95% CI: 0.28-0.83; pregabalin: RR 0.53; 95% CI: 0.35-0.79), antimicrobial and microbiome-associated agents (cefazolin: RR 0.62; 95% CI: 0.45-0.84; clavulanate: RR 0.56; 95% CI: 0.44-0.71; fluconazole: RR 0.36; 95% CI: 0.23-0.58), neuromodulators and adrenergic agents (epinephrine: RR 0.42; 95% CI: 0.31-0.56; propranolol: RR 0.56; 95% CI: 0.37-0.85; salmeterol: RR 0.49; 95% CI: 0.32-0.74; tizanidine: RR 0.29; 95% CI: 0.14-0.57), vascular, metabolic, and hormonal modulators (empagliflozin: RR 0.29; 95% CI: 0.17-0.50; oestradiol: RR 0.47; 95% CI: 0.28-0.81; ezetimibe: RR 0.69; 95% CI: 0.52-0.91; sodium bicarbonate: RR 0.49; 95% CI: 0.29-0.84; spironolactone: RR 0.43; 95% CI: 0.31-0.60), and histamine-related and gastrointestinal agents (famotidine: RR 0.64; 95% CI: 0.55-0.74). Results were consistent in the independent validation using TriNetX network and sensitivity analysis in PMBB database.

INTERPRETATION: 20 widely used medications may be associated with reduced progression from MCI to ADRD and represent promising candidates for clinical evaluation as repurposed therapies for dementia.

FUNDING: National Institutes of Health.

RevDate: 2026-09-04

Tueux G, Pouilly N, Bernigaud Samatan J, et al (2026)

A loss-of-function allele fixed during domestication reshapes nectar chemistry, microbial diversity, and pollinator visits.

Current biology : CB pii:S0960-9822(26)01070-5 [Epub ahead of print].

Nectar is a hub for plant-pollinator interactions, yet gene-level causal links between plant genetic variation, pollinator foraging, and nectar microbial assembly remain poorly resolved. Using near-isogenic lines, innovative field time-lapse monitoring of pollinator visits, and long-read amplicon sequencing of nectar microbiota, we show that a natural single-nucleotide variant at a cell-wall invertase gene (HaCWINV2) controls sunflower nectar chemistry and influences both pollinators and microbes. Plants homozygous for a loss-of-function HaCWINV2 allele produce sucrose-rich nectar, resulting in fewer bee visits under field conditions. In pollinator-excluded flowers, invertase-deficient plants harbored greater fungal diversity and compositionally distinct communities, indicating that nectar sugar profiles act as ecological filters shaping the nectar microbiome. This loss-of-function allele is rare in wild sunflowers, but fixed in 35% of cultivated lines, indicating positive selection during domestication. Our findings establish a causal link between a single gene and nectar chemistry, with cascading ecological effects in a plant-pollinator system, thus illustrating how subtle genetic changes scale up to alter nectar traits, microbial assembly, and pollinator foraging behavior.

RevDate: 2026-09-04

Jiao Y, Cheng CH, Gao X, et al (2026)

Bacteroides acidifaciens enriched by KRAS mutation promotes colorectal tumorigenesis.

Cell host & microbe pii:S1931-3128(26)00352-5 [Epub ahead of print].

Colorectal cancer (CRC) is a multifactorial disease impacted by the tumor microbiome and host genetics, notably mutations that activate KRAS to stimulate a RAF-MEK-extracellular signal-regulated kinase (ERK) proliferative cascade. However, whether host genetics interplays with the tumor microbiome remains unclear. Here, we profiled intratumoral microbiomes from KRAS-mutant CRC patients and intestine-specific oncogenic KRAS[G12D] mice, revealing that KRAS reshapes the microbial community, enriching Bacteroides acidifaciens that predicts poor prognosis in KRAS-mutant CRC patients. Employing isogenic CRC cells and mice with or without mutant KRAS, we demonstrate that B. acidifaciens promotes malignant phenotypes in KRAS-mutant CRC cells and intestine-specific KRAS[G12D] mice but not in wild-type counterparts. B. acidifaciens SusF binds and stabilizes ARHGEF2, which promotes active KRAS and RAF-MEK-ERK signaling. SusF ablation or ARHGEF2 knockout in KRAS-mutant CRC cells abrogates the pro-tumorigenic effects of B. acidifaciens. These observations offer strategies for targeting mutant KRAS-driven B. acidifaciens to mitigate feedforward signaling leading to tumorigenesis.

RevDate: 2026-09-04

Yan H, Qin Q, Li Y, et al (2026)

Multiomics analyses identify diet-derived creatine and α-linolenic acid linking with metastatic thyroid cancer.

Molecular and cellular probes pii:S0890-8508(26)00026-5 [Epub ahead of print].

BACKGROUND: Thyroid cancer (TC) has traditionally been regarded as an indolent malignancy. However, it retains the potential for metastasis and lethality, underscoring its status as a malignant tumor. To explore the interplay between serum metabolite profiles, gut microbial communities, and TC metastasis, we conducted a comprehensive study.

METHODS: Serum metabolites were analyzed using untargeted metabolomics methods to characterize the metabolic changes. Two diet-derived metabolites, creatine (Cr) and α-linolenic acid (ALA), were selected for in vitro validation. Finally, 16S rRNA gene sequencing was used to characterize the intestinal microbial composition and analyze the correlation between differential metabolites and differential intestinal microbiota.

RESULTS: LC-MS analysis of serum metabolites identified Arginine and proline metabolism and Arginine biosynthesis as the primary metabolic pathways altered in TC metastasis. Both Cr and ALA effectively inhibited EMT, migration, and invasion of TC cell lines, TPC1 and FTC-133. The analysis of gut microbiota composition revealed that Cr and ALA showed significant correlations with the bacteria genera, Porphyromonas and Papillibacter.

CONCLUSIONS: This study highlights that TC metastasis is associated with significant alterations in the serum metabolite profiles of patients, and Cr and ALA play a role in inhibiting TC development. Furthermore, Cr and ALA were correlated with Porphyromonas and Papillibacter, implying their potential link with food-borne components and their connected impact on TC metastasis. The findings provide new insights into the role of metabolites and gut microbiota in TC progression, suggesting novel avenues for dietary intervention in cancer treatment.

RevDate: 2026-09-04

Botolin P, Helbing J, Khanuja HS, et al (2026)

Impact of Gastrointestinal Bleeding History on Postoperative Outcomes in Total Hip and Knee Arthroplasty: A Retrospective Analysis.

The Journal of arthroplasty pii:S0883-5403(26)00940-X [Epub ahead of print].

INTRODUCTION: Gastrointestinal (GI) bleeding is common in older adults and contributes to immune dysregulation, yet its impact on total hip (THA) and total knee (TKA) arthroplasty outcomes is poorly understood. We evaluated the association between GI bleeding history with risk of periprosthetic joint infection (PJI) and other complications up to two years following THA and TKA.

METHODS: A retrospective review identified patients who had a history of GI bleeding within two years prior to THA or TKA. Patients were matched to a control cohort who had no GI bleeding history. The THA cohort included 6,420 GI bleed and 6,420 control patients. The TKA cohort included 9,688 GI bleed and 9,688 control patients. Odds ratios were calculated for 90-day and 2-year outcomes.

RESULTS: In the THA cohort, GI bleed within two years prior to surgery was not associated with PJI (odds ratio (OR): 1.1 [0.8 to 1.4]; P = 0.544) at two years; however, it was associated with increased odds of mechanical loosening (OR: 1.6 [1.01 to 2.5]; P = 0.044) and revision surgery (OR: 1.4 [1.1 to 1.8]; P = 0.002). In the TKA cohort, GI bleed history was associated with greater 2-year odds of PJI (OR: 1.3 [1.1 to 1.7]; P = 0.012) and revision surgery (OR: 1.4 [1.2 to 1.7]; P < 0.001). The GI bleed patients in both cohorts demonstrated greater 90-day medical complication odds, including urinary tract infection (P < 0.05).

CONCLUSION: A GI bleeding history was associated with increased 90-day medical and 2-year surgical complications following THA and TKA. Patients undergoing THA had higher odds of mechanical loosening, whereas TKA patients demonstrated higher odds of PJI. While the complication rate was low, these findings should be interpreted cautiously and viewed as hypothesis-generating. Further prospective studies are needed to better characterize postoperative risk factors in this population.

RevDate: 2026-09-04

Luo Y, Jiang Y, Z Tingting (2026)

Targeting Nrf2 in oxidative liver injury: expanding the role of gut microbiota and metabolites.

Journal of advanced research pii:S2090-1232(26)00705-8 [Epub ahead of print].

BACKGROUND: Liver diseases are a major cause of illness and death worldwide. Oxidative stress is a pivotal driver in the pathogenesis of a spectrum of liver diseases, including alcoholic liver disease (ALD), metabolic dysfunction-associated fatty liver disease (MAFLD), drug-induced liver injury (DILI), and hepatocellular carcinoma (HCC). The transcription factor Nrf2, a master regulator of cellular antioxidant responses, plays a central yet context-dependent role in modulating this injury. Additionally, the gut-liver axis is a critical regulator of hepatic homeostasis.

AIM OF REVIEW: This review presents recent advances to propose a refined gut-microbiota-Nrf2 axis as a key mechanistic link in the treatment of liver injury. We detail how specific gut-derived microbial metabolites, such as short-chain fatty acids (SCFAs), tryptophan derivatives, and urolithins, directly or indirectly activate the hepatic Keap1/Nrf2 signaling pathway. This activation orchestrates a cytoprotective program that enhances the redox balance, promotes detoxification, and induces selective autophagy, thereby protecting against oxidative liver injury. Conversely, we examine the dual role of Nrf2, highlighting how its dysregulated and constitutive activation in established HCC can paradoxically promote tumor progression and ferroptosis resistance. Finally, we evaluate the therapeutic potential of targeting this axis using microbiome-modulating strategies, including probiotic and prebiotic supplementation, fecal microbiota transplantation (FMT), dietary intervention, and synergy with Nrf2-targeting drugs.

This review provides an integrated framework that connects gut microbial ecology with host redox signaling, offering novel mechanistic insights and translational perspectives for the prevention and treatment of oxidative liver diseases.

RevDate: 2026-09-04

Sharma A, N Jatana (2026)

Microbiota-derived metabolite-GPCR signalling in neurodegeneration.

Neuroscience pii:S0306-4522(26)00602-0 [Epub ahead of print].

The gut microbiome acts as a primary regulator of host homeostasis, influencing the entire body through bidirectional communication along the gut-brain axis (GBA). Dysbiosis, which is defined as a state of microbial imbalance involving alterations in community composition and function, can disrupt the synthesis of important microbiota-derived metabolites, such as short-chain fatty acids (SCFAs), bile acids and neurotransmitter precursors. This can lead to impaired essential host signalling pathways. There is growing evidence that metabolic alterations associated with dysbiosis contribute to the onset and progression of neurodegenerative disorders (NDDs), including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). In this context, G protein-coupled receptors (GPCRs) act as essential molecular transducers that link microbial metabolites to intracellular signalling networks. Aberrant GPCR activation, driven by altered metabolite profiles, modulates key downstream pathways including cAMP, MAPK, PI3K/Akt, NF-κB and Ca2 + signalling. This promotes neuroinflammation, oxidative stress, mitochondrial dysfunction and pathological protein aggregation - hallmark processes underlying neurodegeneration. By identifying convergent and disease-specific signalling pathways, the review highlights mechanistic nodes of therapeutic relevance and discusses GPCR-centric emerging and other microbiome-targeted strategies aimed at restoring metabolic and signalling homeostasis in neurodegenerative disorders.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Gao Y, Chen J, Zhang Y, et al (2026)

Pseudomonas chlororaphis YL21 synergistically controls Fusarium crown rot of wheat by reshaping rhizosphere microbiota and reprogramming host defense metabolism.

Pesticide biochemistry and physiology, 223:107261.

Fusarium crown rot (FCR) poses a major threat to wheat (Triticum aestivum L.) production worldwide, with severe outbreaks occurring in the Xinjiang Uygur Autonomous Region, China. As a soil-borne disease caused by Fusarium species, FCR is considered difficult to detect and manage, which often leads to poor control efficacy. Therefore, developing novel green biocontrol agents represents an urgent scientific challenge. Here, we report a rhizosphere bacterium, Pseudomonas chlororaphis YL21, which exhibits strong antagonistic activity against Fusarium spp. Inoculation with P. chlororaphis YL21 significantly reduced FCR severity and promoted plant growth. This strain produces proteases that inhibit pathogens, as well as plant growth-promoting factors including nitrogen fixation, siderophores, hydrogen cyanide (HCN), indole-3-acetic acid (IAA), and ammonia. ITS and 16S rRNA sequencing revealed that strain YL21 substantially reshaped the rhizosphere microbiota structure and promoted the enrichment of other beneficial microorganisms. RNA-Seq showed upregulation of plant hormone signal transduction and vitamin B6 metabolism pathways, as well as defense-related genes including PR1 and RPM1. Untargeted metabolomics revealed substantial metabolic changes in the wheat stem base following YL21 inoculation, with metabolites such as xanthoxylol, dihydrochelerythrine, and zeanic acid being significantly upregulated. Plants reprogrammed key metabolic pathways, including glucosinolate biosynthesis, ABC transporters, and the biosynthesis of various plant secondary metabolites, collectively indicating activated defense responses. This work elucidates the biocontrol mechanisms of P. chlororaphis against Fusarium by integrating metabolomics, transcriptomics, and microbiome analyses. Our findings lay a solid foundation for developing sustainable approaches to manage FCR in wheat.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Huang C, Dai X, Chen Y, et al (2026)

Chitosan mitigates the dissemination of antibiotic resistance genes caused by metalaxyl in the soil-earthworm system.

Pesticide biochemistry and physiology, 223:107278.

The widespread use of agricultural fungicides can lead to residual contamination and accelerate the emergence and spread of antibiotic resistance genes (ARGs) and antibiotic-resistant bacteria (ARBs) in soil ecosystems. Developing green remediation strategies that simultaneously reduce fungicide residues and mitigate antibiotic resistance risks is therefore beneficial for soil pollutant control. Here, we investigated the effects of chitosan (CHI) on the dissipation of metalaxyl (MET) enantiomers and their influence on the soil-earthworm resistome and microbiome through pot experiments and metagenomics analysis. The results showed that CHI significantly accelerated MET dissipation in soil and reduced its bioaccumulation in earthworms. MET enantiomers, particularly S-MET, promoted the dissemination of ARGs, including high-risk ARGs, in the soil-earthworm system, whereas CHI suppressed these effects, likely by limiting the potential for mobile genetic element (MGE)-mediated horizontal gene transfer (HGT). Compared with the corresponding treatments without CHI amendment, CHI amendment reduced the total relative abundance of ARGs by 16.8%-24.7% in soil and by 34.1%-58.3% in earthworm guts. Furthermore, CHI reshaped microbial community structure in both soil and earthworm gut samples by driving ecological niche differentiation of Actinomycetota and Pseudomonadota and reduced ARG host abundance. These findings offer practical insights for controlling contamination by fungicides and ARGs in agricultural soils.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Zhu S, Liu X, Yang X, et al (2026)

Amplicon and metagenomic sequencing reveal thifluzamide drive rhizosphere microbial structural shifts and functional adaption.

Pesticide biochemistry and physiology, 223:107299.

Thifluzamide (TF) is a widely used phenyl urea fungicide in rice production; however, its impacts on the structural composition and functional dynamics of the rhizosphere microbiome remain poorly understood. Here, we systematically investigated the effects of TF on the structure, interactions, and functional potential of the rice (Oryza sativa L.) rhizosphere microbiome using integrated amplicon sequencing and metagenomic approaches. TF application significantly altered both bacterial and fungal community composition, bacterial diversity was markedly reduced, whereas fungal diversity increased. With bacterial diversity markedly reduced while fungal diversity increased. Beta-diversity analyses revealed strong treatment-driven community separation, indicating pronounced TF-induced microbial restructuring. Co-occurrence network analysis demonstrated reduced complexity and connectivity in bacterial networks but increased negative co-occurrence patterns within fungal communities, suggesting contrasting stability responses between microbial kingdoms. Metagenomic profiling further revealed substantial functional shifts, including the differential enrichment of KEGG and COG pathways associated with xenobiotic metabolism. Notably, while total ARG abundance remained stable, TF exposure altered the resistome profile by selectively enriching specific classes of antibiotic resistance genes (ARGs), biocide resistance genes (BRGs), and mobile genetic elements (MGEs). Strong positive correlations between MGEs and ARGs highlighted an elevated potential for horizontal gene transfer. Metagenome-assembled genome (MAG) analysis identified specific TF-enriched bacterial taxa, including Methylophilus, Sulfurospirillum, and Azospirillum, which harbored genes involved in pesticide degradation and xenobiotic transformation. Collectively, these findings demonstrate that TF profoundly reshapes the rice rhizosphere microbiome by altering microbial diversity, interaction networks, resistance gene profiles, and functional capacities. This study provides genomic insights into fungicide-microbiome interactions, underscoring the potential ecological implications associated with TF application, while identifying candidate microbial taxa that may contribute to pesticide degradation and rhizosphere microecology resilience.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Nie F, He Z, Zhang L, et al (2026)

Kojic acid and ε-poly-L-lysine suppress potato common scab and remodel the tuber-associated microbiome.

Pesticide biochemistry and physiology, 223:107314.

Potato common scab (PCS) is an economically important soil-borne disease whose occurrence is governed not only by pathogen virulence but also by the disease-associated microbiome and soil environment. However, studies on natural bioactive compounds have primarily focused on direct pathogen inhibition, whereas their roles in microbiome remodeling remain largely unexplored. Here, we investigated the antibacterial activity of kojic acid (KA) and ε-poly-L-lysine (ε-PL) against Streptomyces scabies and evaluated their effects on PCS severity and the tuber-associated microbiome. Both KA and ε-PL significantly inhibited the growth of Streptomyces scabies G9, with ε-PL exhibiting stronger in vitro antibacterial activity. Both treatments disrupted hyphal ultrastructure, increased membrane permeability, and triggered extensive transcriptional reprogramming involving cell envelope organization, central metabolism, membrane transport, and genetic information processing. Net-house and field trials showed that both compounds substantially reduced disease severity; significant yield increases were observed in the net-house trial, whereas no significant yield differences were detected among treatments in the field trial. Microbiome analyses revealed that both compounds improved the physicochemical properties and enzyme activities of tuber-associated soil, reshaped the composition and predicted functional profiles of the tuber-associated bacterial community, and reduced the relative abundance of pathogen-associated Streptomyces taxa. Correlation analyses revealed significant associations among soil environmental factors, pathogen-associated Streptomyces taxa, and disease occurrence. Collectively, these findings indicate that KA and ε-PL suppress PCS in association with direct antibacterial activity and remodeling of the tuber-associated bacterial community. This study provides insights into the potential roles of natural bioactive compounds in pathogen suppression and microbiome modulation.

RevDate: 2026-09-04

Armengaud C, Protto V, Poitout A, et al (2026)

Decoupling developmental and physiological adaptations: a strategy to unleash nutrient use efficiency in plants?.

Trends in plant science pii:S1360-1385(26)00250-5 [Epub ahead of print].

Plants respond to spatially and temporally variable soil nutrients through root architectural plasticity, regulation of uptake and assimilation per root unit, and plant-soil-microbiome interactions. Although often viewed as complementary, these responses can also behave as compensatory strategies. Under non-optimal nutrient distributions, plants may invest either in greater root proliferation or in higher uptake capacity per root unit. We propose that this development-transport relationship should be understood as an optimization problem, rather than an additive response. Comparable morphology-physiology trade-offs occur in other resource-acquiring organs, including the gut and the lungs. Tuning or partially uncoupling these constraints could redefine crop ideotypes as dynamic combinations of root architecture, physiological elasticity, and controlled rhizosphere outsourcing, opening new routes to improve nutritional efficiencies.

RevDate: 2026-09-04

Ho PM, Nazeer RR, Askenasy I, et al (2026)

Microbial content versus microbial interaction: the impact of medications on CF airway microbial ecosystems.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society pii:S1569-1993(26)03732-X [Epub ahead of print].

BACKGROUND: The airways of people with cystic fibrosis (pwCF) are often colonized by a variety of different microbes. Although much effort has been put into cataloguing the impact of medication on the identities and abundances of these microbes, far less has been directed towards examining this from an ecological perspective, i.e., examining how medications affect the network and types of interactions between microbes.

METHODS: In the current work, we generated an ecological model of the CF airway microbiome and examined how medications affect interactions between co-habiting airway microbiota in six pwCF. Ecological interactions were inferred from a generalized Lotka-Volterra model, and the impact of medications was determined by principal component(s) regression analysis.

RESULTS: For the majority of the subjects studied, antimicrobial interventions had relatively little impact on the CF airway microbial ecology, and even appeared to stabilize ecological interactions between the microbiota. However, the microbial ecosystem in some individuals was more sensitive to external perturbations. More surprisingly, we found that some non-antimicrobial medications, and also certain carriers and excipients affect the ecosystem.

CONCLUSIONS: Medications affect the ecology of the CF airway microbiota. These impacts appear to be very patient-specific. We also note that some nominally non-bioactive ingredients in medications can also potentially impact the CF airway ecosystem. Our data highlight the importance of collecting patient-specific data and in employing suitable computational frameworks for disentangling medication-microbiota interactions in vivo.

RevDate: 2026-09-04

Htut M, Lee K, Nathwani N, et al (2026)

Gut Microbiome Composition Is Associated With Response to CD38 Antibody (Daratumumab) Treatment Among Relapsed Multiple Myeloma Patients.

Clinical lymphoma, myeloma & leukemia pii:S2152-2650(26)00254-5 [Epub ahead of print].

INTRODUCTION: Growing data support interactions between host-gut microbes and treatment responses in multiple myeloma (MM), where a higher abundance of Eubacterium hallii in stool samples has been found among MM patients with negative minimal residual disease after induction therapy. Here, we evaluated changes in the gut microbiome associated with daratumumab (dara) based therapy in 40 MM patients, before and after therapy.

PATIENTS AND METHODS: Patients with relapsed MM and prior autologous transplantation who had received 1 to 4 prior lines of therapy were eligible. Two stool samples were collected, one within 1 week prior to dara (predara) and one immediately after 4 doses of dara (postdara). Metagenomics sequencing was conducted. Microbiome taxonomic analyses were performed using MetaPhlAn4, and microbial functional pathway analyses were conducted using HUMAnN3.6. QIIME2 was used for compositional and statistical analyses.

RESULTS: Of 40 participants enrolled, there were 5 nonresponders; 35 patients achieved partial response (PR) or better (responders). Among responders, 10 patients achieved complete remission (CR), and 25 patients achieved either very good partial response (VGPR) or PR. There were no statistically significant differences between overall pre and postdara gut microbiomes. Differential abundance analysis (ANCOM-BC) showed statistically significant (q ≤ 0.05) overgrowth of Alistipes finegoldii and Acidaminococcus intestini species in responders and Ruminococcus torques, Sellimonas intestinalis and Clostridium symbiosum in nonresponders. Compared to non-CR, CR samples showed enrichment of Faecalibacterium prausnitzii; non-CR samples were enriched in Segatella copri and Faecalimonas umbilicata.

DISCUSSION/CONCLUSION: Our results suggest differences in species between clinical responders and nonresponders, but larger prospective studies are needed to confirm these results.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Galal A, Moustafa A, M Salama (2026)

Proteo-metabolomic integration identifies stage-specific candidate biomarkers for Parkinson's disease.

NPJ Parkinson's disease, 12(1):.

Parkinson's disease (PD) is a progressive neurodegenerative disorder with a prolonged prodromal phase and complex motor symptoms. Despite improved clinical criteria, early diagnosis and longitudinal monitoring remain challenging. While cerebrospinal fluid (CSF) and plasma metabolites and proteins show biomarker potential, their utility in predictive models is insufficiently characterized. We employed a secondary computational approach to integrate proteometabolomic profiles from CSF and plasma samples of >1100 Parkinson's Progression Markers Initiative (PPMI) participants. Using multi-omics machine learning, we identified biofluid-specific signatures and evaluated predictive performance. Twenty-one biomarker candidates were validated across three models (SVM, GLMNET, RF); SVM and GLMNET achieved the highest recall (83-86%) and AUCs of 0.84-0.89. Longitudinal mixed-effects modeling revealed eight candidates associated with progression across diagnostic stages. We identified a three-part molecular framework characterizing neurodegeneration: a diagnostic subpanel reflecting early microbiome dysregulation (secretory granins and metabolites) and synaptic breakdown; a second subpanel monitoring phenoconversion via neurogenesis precursors and extracellular matrix proteins; and a third subpanel tracking progression through chronic neuroinflammation and immune activation. This integrated multi-omics approach provides a robust framework for stage-specific PD monitoring and potential clinical deployment.

RevDate: 2026-09-05

Tang W, Nordmann-Gomes A, Khalili L, et al (2026)

Updates on the Evaluation of Lupus Arthritis.

Rheumatology and therapy [Epub ahead of print].

Lupus arthritis is the most common manifestation of systemic lupus erythematosus (SLE), affecting up to 95% of patients. Clinical presentations range from inflammatory arthralgia and non-deforming non-erosive (NDNE) synovitis to Jaccoud arthropathy and erosive arthritis, reflecting substantial clinical heterogeneity. Despite its high prevalence, widely used outcome measures lack the granularity to distinguish between these phenotypes or accurately quantify disease severity. This narrative review integrates clinical phenotypes, serologic biomarkers, imaging advances, and emerging therapies to provide a framework for evaluating lupus arthritis. Besides distinct clinical phenotypes, we propose a conceptual hypothesis-generating model describing the evolution of lupus arthritis. In an early, preclinical stage, genetically predisposed individuals may develop pathogenic autoantibodies and alterations in the gut microbiome that can lead to increased inflammation within the synovium. The intermediate stage is characterized by progressive leukocyte accumulation within the joint space, leading to clinical symptoms and early abnormalities on imaging including joint effusions, synovitis, and tenosynovitis. In the late stage, persistent inflammation results in clinically evident joint damage, including synovial hypertrophy, joint capsular swelling, and bone erosions. Biomarkers such as anti-citrullinated protein antibodies (ACPAs), anti-carbamylated protein (anti-carP) antibodies, interleukin (IL)-6, IL-17, and metalloproteinases may help identify patients at risk for erosive or deforming disease and those prone to rapid progression. Advances in imaging technologies including musculoskeletal ultrasound (MSK-US), MRI, and optical tomography may enable earlier detection before clinical manifestations or physical exam findings, creating opportunities for earlier intervention. Therapeutically, hydroxychloroquine (HCQ) remains the foundation of treatment. Belimumab and anifrolumab are US Food and Drug Administration (FDA)-approved biologics now recommended as standard of care for persistent disease, alongside conventional immunosuppressants such as methotrexate, mycophenolate, or azathioprine when indicated. Additional targeted therapies including obinutuzumab and Janus kinase (JAK) inhibitors are closely following behind. Chimeric antigen receptor T cell (CAR-T) represents a promising approach that may transform the future management of SLE.

RevDate: 2026-09-05

Li M, Cui J, Qu R, et al (2026)

Correction: Porphyromonas gingivalis induces intestinal inflammation through gingipain-dependent gut microbiome dysbiosis.

Microbiome, 14(1):.

RevDate: 2026-09-05
CmpDate: 2026-09-05

Turon M, Díez-Vives C, Carrier TJ, et al (2026)

Phagocytosis of microbial symbionts supports embryonic nutrition in the sponge Halichondria panicea.

Microbiome, 14(1):.

BACKGROUND: Animal development is frequently supported by microbial symbionts that contribute to host nutrition, metabolism, and physiology. While the functional importance of microbiomes in adult hosts is increasingly recognized, the role of symbiotic microbes during gametogenesis and embryogenesis remains poorly understood, particularly in early-diverging metazoans. Sponges represent an ideal system to investigate these processes due to their dense and diverse microbial communities. Here, we examined host-symbiont dynamics across the reproductive cycle of the marine sponge Halichondria panicea to assess how microbial communities contribute to reproduction and early development.

RESULTS: Specimens were collected monthly from February to July and classified by reproductive stage using histological analyses. We combined ultrastructural imaging, dual RNA sequencing of host and symbionts, 16S rRNA gene amplicon sequencing, and quantitative PCR to characterize microbial and transcriptional dynamics throughout reproduction. Pronounced shifts in both host gene expression and microbial community composition occurred during early embryogenesis, particularly in May. Transmission electron microscopy revealed nurse cells phagocytosing bacterial aggregates in close proximity to late oocytes, presumably converting them into yolk precursors. This coincided with a significant decline in the abundance of the dominant obligate symbiont, Candidatus Halichondribacter symbioticus. Host transcriptomic analyses showed upregulation of immune and phagocytic pathways, including pattern recognition receptors, lectins, and vesicle trafficking components, specifically in females undergoing embryogenesis in May. Concurrently, symbiont gene expression profiles indicated responses to acidic conditions, consistent with exposure to phagosomal environments.

CONCLUSIONS: Our results are consistent with intracellular digestion of microbial symbionts during early embryogenesis, potentially to supplement the nutritional requirements of embryogenesis. These findings reveal symbiont phagocytosis as a previously underappreciated nutritional strategy during animal development and highlight the dynamic functional integration of microbiomes into reproductive physiology in basal metazoans. Video Abstract.

RevDate: 2026-09-05

Ríos-Barbero J, Martínez M, Ambrosio N, et al (2026)

Periodontitis and Neuropsychiatric Disorders: Epidemiological and Mechanistic Evidence.

Journal of periodontal research [Epub ahead of print].

This review aims to critically analyze the epidemiological evidence and mechanistic insights linking periodontitis with the onset, progression, or severity of neuropsychiatric disorders. From an epidemiological perspective, eligible evidence was identified regarding disorders related to trauma, stress, anxiety, depressive, and bipolar disorders, whereas no studies meeting the predefined inclusion criteria were found for the remaining considered disorders. The strongest epidemiological evidence was observed for depressive disorders and anxiety- and stress-related conditions. However, the predominance of cross-sectional studies, together with substantial methodological heterogeneity, limits conclusions regarding temporality and causality. From a mechanistic perspective, the available evidence regarding the association between periodontitis and neuropsychiatric disorders predominantly supports as mechanisms (1) microbial pathways (microbial translocation and functional dysregulation of the oral microbiome), (2) inflammatory and immune pathways (systemic (meta)inflammation and trafficking of immune players systemic), and (3) shared underlying vulnerabilities (behavioral factors, medication-related effects, lifestyle and systemic health factors, and genetic mechanisms). Periodontitis may promote a persistent low-grade systemic inflammatory state through the release of bacterial products and inflammatory mediators into the circulation, thereby influencing immune, neuroendocrine, and vascular pathways relevant to neuropsychiatric vulnerability. Moreover, the hematogenous dissemination or swallowing of periodontal bacteria and their virulence factors may contribute to microbial remodeling at distant sites, including the gut, supporting the concept of an oral-gut-brain axis. Overall, the evidence analyzed supports periodontitis as a potential modifiable contributor within a broader biopsychosocial network linking oral and mental health, while highlighting the need for longitudinal studies and interventional trials to clarify causality and clinical relevance.

RevDate: 2026-09-05
CmpDate: 2026-09-05

Murugesan M, Thankappan S, Mageshwaran V, et al (2026)

Decoding the functional diversity of plant growth-promoting bacterial communities in the soils of Western Ghats, Tamil Nadu, India.

Frontiers in microbiology, 17:1865342.

Western ghats in India, one of the world's biodiversity hot spots is the reservoirs of microbial resources having agricultural and industrial significance. However, the diversity of plant growth-promoting microbial communities associated with the plants and soil in the Western Ghats is untapped vault. The current emphasis on natural farming is more depending on the indigenous microbial communities and their metabolic functions towards sustainable one -health. With this background, the present study examines the bacterial diversity of soils from the Western Ghats of Nilgiris, Coimbatore and Dindigul regions. Among the 10 soil samples collected (S1 to S10), three soil samples (S2, S4 and S6) representing respective three regions were subjected for metagenomic studies based on their distinct soil chemical and biological properties. The computational analysis of the metagenome revealed the core genus Bradhyrhizobium in all soil samples, while Trebonia, Arthrobacter, Streptomyces, and Pseudomonas are the next most abundant genera, which varied substantially. The results collectively demonstrate that soil sample from Dindigul harbours the richest and most diverse microbial community among the three regions. In culturable studies, a total of 101 bacterial isolates were obtained from 10 soil samples (S1 to S10). Among them four Gram-negative bacterial isolates showed potential plant growth-promoting attributes, such as Ammonia, Indole Acetic Acid, Hydrogen cyanide and siderophore production, phosphorus, potassium, and zinc solubilization. The 16S rDNA analysis revealed that the bacterial isolates were Pseudomonas glycinae S6B1, Pseudomonas tolaasii S2B3, Pseudomonas azotoformans S9H10, and Pseudomonas poae S10B2. The isolate, S10B2, exhibited the maximum inhibition, with 81.25%, 70.1%, and 35% against plant pathogenic fungi, Rhizoctonia solani, Sclerotium rolfsii, and Fusarium oxysporum, respectively, indicating strong biocontrol potential. The effect of bacterial inoculants on chick pea (Cicer arietinum var. JG 62), showed that P. glycinae S6B1 significantly promoted plant growth such as root length, shoot length, and fresh/dry biomass. These findings unlock the core microbiome of soils of Western Ghats, which can be utilized to develop a synthetic microbial consortium to boost agricultural productivity.

RevDate: 2026-09-05
CmpDate: 2026-09-05

Park J, Cheon S, Choi YS, et al (2026)

Anaerobic antibiotic exposure and risk of maculopathy: a nationwide dual design study.

Frontiers in pharmacology, 17:1840229 pii:1840229.

The pathogenesis of maculopathy remains incompletely understood, and emerging evidence implicates the gut-eye axis in retinal and macular diseases. Given that antibiotics with anti-anaerobic activity may disrupt gut microbial ecology, this study investigated their association with the risk of incident maculopathy. We conducted a nationwide population-based study using the National Health Insurance Service-National Sample Cohort of South Korea. A retrospective cohort study was used to assess cumulative systemic anaerobic antibiotic exposure during a 5-year baseline period and subsequent incident maculopathy from 2007 to 2019. After 1:1 propensity score matching, hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards regression. A nested case-control study was also conducted using risk-set sampling and 1:10 propensity score matching. Anaerobic antibiotic exposure during the 365 days before the index date was assessed, and odds ratios (ORs) and 95% CIs were estimated using conditional logistic regression. Duration-response relationships were evaluated using formal trend analyses. Sensitivity analyses included age restriction, Fine-Gray competing risk models, extended exposure assessment windows, lag-time analyses, and a negative control comparator analysis using first-generation cephalosporins. In the retrospective cohort study, 326,436 anaerobic antibiotic users were matched to 326,436 non-users. Anaerobic antibiotic use was associated with an increased risk of incident maculopathy in the fully adjusted model (HR, 1.07; 95% CI, 1.03-1.12), with a significant duration-response trend and the highest risk observed for ≥57 days of cumulative use (HR, 1.24; 95% CI, 1.09-1.42). In the nested case-control study, 55,776 cases were matched to 557,760 controls. Anaerobic antibiotic use within 365 days before the index date was associated with increased odds of maculopathy (OR, 1.04; 95% CI, 1.02-1.07), also showing a significant duration-response trend. Sensitivity analyses and first-generation cephalosporin comparator analyses, generally supported the robustness of the findings. Systemic exposure to antibiotics with anti-anaerobic activity was associated with an increased risk of incident maculopathy, with a duration-response pattern across cumulative exposure categories. These findings suggest further investigation into gut microbiome disruption and the gut-eye axis as potential pathways involved in maculopathy.

RevDate: 2026-09-05
CmpDate: 2026-09-05

Elhennawy F, Naji B, AE Butler (2026)

The gut microbiome in polycystic ovary syndrome: mechanistic pathways and therapeutic potential of microbiota-targeted interventions.

Frontiers in endocrinology, 17:1900535.

Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders worldwide, affecting 6-13% of reproductive-aged women and exerting a profound metabolic, reproductive and psychological toll. Emerging evidence suggests that the gut microbiome may be a potentially critical, yet under-recognized, contributor to the pathophysiology of PCOS. Alterations in microbial composition and function appear to influence hormonal imbalance, metabolic dysfunction and inflammatory processes that characterize the condition. However, much of the current evidence remains associative or derived from preclinical models, and the causal nature of these relationships is only beginning to be established through approaches such as Mendelian randomization. This literature review examines the evolving relationship between the gut microbiome and PCOS through a mechanism-guided, evidence-stratified framework, with particular focus on how microbiota-targeted interventions - including prebiotics, probiotics, synbiotics, dietary modifications and fecal microbiota transplantation, may modulate gut health and mitigate symptom severity. Across the reviewed studies, microbiome-targeted supplementation was associated with improvements in insulin sensitivity, reductions in systemic inflammation and favorable hormonal changes, although the strength of evidence varies across outcomes and intervention types. Importantly, PCOS heterogeneity, including differences in body mass index (BMI), insulin resistance status and phenotype, may influence both gut microbiota composition and therapeutic response, underscoring the need for phenotype-stratified research. These findings suggest that targeting the gut microbiome may serve as a promising adjunct to conventional PCOS management. Though further rigorous, long-term clinical trials are needed to advance both understanding and clinical translation.

RevDate: 2026-09-05
CmpDate: 2026-09-05

Saud Gany SL, Mohd Sahardi NFN, Rusli N, et al (2026)

Natural products as modulators of age-associated gut microbiota dysbiosis: a systematic review of animal models.

Frontiers in pharmacology, 17:1809547 pii:1809547.

UNLABELLED: Ageing is increasingly recognised as a microbiota-driven process, with dysbiosis contributing to oxidative stress, chronic inflammation, and cognitive and functional decline. Natural products, long valued in traditional medicine, are emerging as targeted modulators of the gut ecosystem. This systematic review synthesised current evidence on natural product interventions in ageing animal models. Searches of four databases (2000-2024) yielded 762 records, of which 17 studies met eligibility criteria, encompassing naturally aged rodents, D-galactose-induced, genetically accelerated (SAMP8, ob/ob), and diet-induced models. Interventions spanned plant-derived compounds, probiotics, prebiotics, marine microalgae, and animal-derived products. Across models, natural products frequently normalized microbial communities, lowering the Firmicutes/Bacteroidetes ratio, suppressing pro-inflammatory taxa (Helicobacter, Desulfovibrio), and enriching beneficial genera (Lactobacillus, Bifidobacterium, Akkermansia). These shifts are linked to improved systemic outcomes, including enhanced antioxidant defences (SOD, GSH-Px, CAT), reduced levels of inflammatory mediators (IL-6, TNF-α, COX-2), and gains in memory, learning, and motor performance. Taken together, these findings demonstrate that natural products exert multi-targeted benefits in ageing by restoring microbial balance and attenuating hallmarks of decline. Yet, wide heterogeneity in animal models, intervention types, and outcome measures limits comparability. Standardised, long-term, and multi-omics approaches are urgently needed to establish mechanistic pathways and accelerate translation into human ageing interventions.

https://www.crd.york.ac.uk/PROSPERO/view/CRD420250602174.

RevDate: 2026-09-05
CmpDate: 2026-09-05

Cioletti G, Kenney S, Hovingh E, et al (2026)

Nasopharyngeal microbiome and resistome profiles in dairy calves fed milk replacer with low-level β-lactams.

JDS communications, 7(5):670-677 pii:S2666-9102(26)00101-8.

Feeding waste milk (WM) to preweaning dairy calves is a common management practice that offers economic benefits but may influence the microbiome and antimicrobial resistance (AMR) due to the presence of antibiotic residues. The objective of this study was to describe longitudinal patterns in the nasopharyngeal microbiome and AMR gene profiles of dairy calves fed either nonsupplemented milk replacer or milk replacer supplemented with low-level β-lactam antibiotics to simulate WM exposure during the preweaning period. Using shotgun metagenomic sequencing, we profiled the nasopharyngeal microbiome and resistome of 11 Holstein bull calves fed milk replacer with (MR+A; n = 6) or without (MR; n = 5) low levels of β-lactam antibiotics. Antibiotic concentrations were selected to reflect residue levels reported in WM. Deep nasopharyngeal swabs were collected every 2 wk from 1 to 15 wk of age; samples from wk 3 and 15 were excluded due to elevated contaminant burden, resulting in 6 retained time points. No significant differences in microbial α-diversity, β-diversity, or community structure were detected by dietary treatment or sampling age. Tetracycline, macrolide-lincosamide-streptogramin, aminoglycoside, metal, acid, and biocide resistance classes were among the most prominent, with descriptive differences in z-score patterns between groups but no significant differences detected. Larger-scale studies are needed to evaluate the long-term effects of WM feeding on respiratory health and AMR dynamics in dairy calves.

RevDate: 2026-09-05
CmpDate: 2026-09-05

Kumar M, Almohannadi N, S Al Khodor (2026)

Decoding the power of the microbiome in human health.

Frontiers in cellular and infection microbiology, 16:1877371.

The human microbiota plays a vital role in maintaining physiological homeostasis and overall health. Microbial communities colonize distinct anatomical sites, including the gut, oral cavity, respiratory tract, and skin, where they engage in symbiotic interactions with the host. These site-specific microbial communities contribute to essential functions such as nutrient metabolism, vitamin and short-chain fatty acid (SCFA) synthesis, immune regulation, and epithelial barrier integrity. Disruption of this balance, known as dysbiosis, is increasingly linked to a wide range of diseases, including inflammatory bowel disease (IBD), obesity, diabetes, and cancer. In this review, we summarize the current understanding of the human microbiota, highlighting its role in vitamin biosynthesis, the gut-brain axis, and immune modulation. We further the role of microbiome alterations in disease pathogenesis and outline emerging microbiome-based therapeutic strategies aimed at restoring microbial homeostasis.

RevDate: 2026-09-05
CmpDate: 2026-09-05

Zhang S, Si Z, Yang N, et al (2026)

Exposure-aware multi-omics and artificial intelligence for biomarker discovery and precision prevention in diffuse glioma.

Frontiers in immunology, 17:1874861.

Diffuse gliomas are now diagnosed and studied through integrated molecular classification, radiomics, single-cell biology, spatial profiling, proteogenomics, metabolomics, and artificial intelligence. Yet many precision-medicine models still begin at diagnosis and emphasize tumor-intrinsic molecular features, leaving environmental, occupational, lifestyle, microbiome, metabolic, immune, and treatment-related exposures at the margins. This review develops an exposome-informed view of diffuse glioma biomarker discovery. Biomarker discovery is separated from clinical prevention: current evidence does not justify population-level glioma screening based on environmental exposures, but it does support systematic integration of external exposures and internal exposure-related molecular states with tumor and host biology. The synthesis focuses on five linked dimensions: the limits of current artificial intelligence and multi-omics models when exposure biology is excluded; glioma-relevant exposure domains stratified by evidence strength and measurability; genotoxic, epigenetic, vascular, neuroimmune, and immunometabolic conduits through which exposures may shape tumor ecology; computational strategies for temporally anchored integration of geospatial, occupational, clinical, liquid-biopsy, imaging, tumor-omic, single-cell, spatial, microbiome, and metabolomic data; and clinically realistic applications in high-risk surveillance, recurrence-aware monitoring, treatment-toxicity reduction, and biomarker-guided trial stratification. By aligning exposome science with systems neuro-oncology, the review outlines a translational agenda for exposure-aware glioma biomarkers while maintaining a conservative boundary between established evidence, mechanistic hypotheses, and future clinical implementation.

RevDate: 2026-09-05
CmpDate: 2026-09-05

Jin H, Sun H, J Yang (2026)

Microbiome-based diagnostic biomarkers in pancreatic ductal adenocarcinoma: Current evidence and translational challenges (Review).

Oncology letters, 32(4):478 pii:OL-32-4-15833.

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, as the majority of patients are diagnosed at an advanced disease stage. CA19-9, the biomarker most commonly used in clinical practice, lacks adequate sensitivity and specificity for early PDAC detection. Increasing evidence indicates that alterations in gut, oral and tumor-associated microbiota are associated with PDAC development and progression, supporting the potential diagnostic value of microbiome-based biomarkers in this disease. Multiple diagnostic models have been developed for PDAC using fecal, salivary or tissue-derived microbial profiles, and the combination of microbial signatures with CA19-9 or metabolomic markers has improved diagnostic performance in a number of cohorts. Despite these advancements, the clinical translation of microbiome-based models remains limited by methodological heterogeneity, patient-related variability, low levels of microbial biomass in pancreatic tissue and a lack of large-scale prospective validation. In addition, the majority of available evidence for microbiota-based alterations in PDAC is derived from retrospective case-control studies, and the reported diagnostic performance should therefore be interpreted cautiously. The present review summarizes current evidence on PDAC-associated microbial alterations and microbiome-based diagnostic models, and discusses the methodological, biological and regulatory challenges that must be addressed before microbiota-based approaches can be integrated into routine clinical practice.

RevDate: 2026-09-05
CmpDate: 2026-09-05

Prachansuwan A, Sukkha P, Thiyajai P, et al (2026)

Gut microbiome and metabolic responses to cricket powder supplementation in Thai subjects with high or borderline-high LDL cholesterol: an exploratory, randomized, crossover controlled trial.

Current research in food science, 13:101536 pii:S2665-9271(26)00236-4.

Edible insects are emerging as sustainable functional foods, yet human evidence for microbiome-mediated effects remains limited, particularly in Asian populations. Therefore, this study investigated whether cricket powder supplementation modulates gut microbiome composition and metabolic outputs in Thai subjects with high or borderline-high LDL cholesterol. In a randomized, crossover controlled trial, 17 subjects received cricket powder or control products for 21 days, separated by a 4-week washout. Gut microbiome composition was profiled using full-length 16S rRNA gene sequencing, and fecal short-chain fatty acids (SCFAs) were quantified by gas chromatography-mass spectrometry. Blood lipids and gastrointestinal tolerance were also assessed. As a result, cricket powder did not alter overall microbial diversity or community structure but induced targeted species-level shifts, including enrichment of Blautia faecis and Mediterraneibacter glycyrrhizinilyticus. Despite these compositional changes, fecal SCFAs remained unchanged. Notably, branched-chain SCFAs were not increased, indicating no shift toward proteolytic fermentation and preservation of microbial metabolic balance. Gastrointestinal tolerance was maintained without adverse effects. Blood lipid parameters were unchanged, with a modest trend toward increased high-density lipoprotein cholesterol (HDL-C). Collectively, cricket powder induces selective microbiome remodeling without disrupting metabolic homeostasis, supporting its potential as a sustainable, microbiome-targeted functional food.

RevDate: 2026-09-03

Browning BD, Kirkland AE, Meredith LR, et al (2026)

Within- and Between-Visit Variability and Reproducibility of the Oral Microbiome in Young Adults with Alcohol Use Disorder.

Alcohol (Fayetteville, N.Y.) pii:S0741-8329(26)00233-8 [Epub ahead of print].

BACKGROUND: The oral microbiome has emerged as a potential biomarker and pharmacological target in alcohol use disorder (AUD) due to its associations with alcohol use and related biological processes. However, its temporal variability and reproducibility remain poorly understood, limiting its utility.

METHODS: Saliva samples were obtained from participants enrolled in a randomized controlled trial of young adults with AUD. Temporal variability and reproducibility were evaluated using within-visit samples (∼4 hours apart; before and after sesame oil placebo and standardized snack) and between visits (∼25 days; pre-treatment). Alpha diversity, beta diversity, differential abundance, and intraclass correlation coefficients (ICCs) were calculated at the genus and species levels.

RESULTS: Significant within-visit differences were observed in alpha diversity, beta diversity, and the abundance of several genera and species. Snack type and time since last alcohol use explained comparable or greater variance in microbial composition than within-visit timepoint (4-6%). Although reproducibility of alpha diversity within-visit was generally low, most genera (70.3%) and species (74.6%) demonstrated at least moderate reproducibility. In contrast, no detectable systematic between-visit differences were observed in diversity or taxon abundance, and reproducibility was generally moderate for alpha diversity measures and most genera (67.6%) and species (72.2%).

CONCLUSIONS: Despite group-level microbial shifts within-visit, individual-level microbial features were generally reproducible both within (∼4 hours) and between (∼25 days) visits. No systematic group-level differences were detected between-visits.These findings support the use of the oral microbiome in AUD research while emphasizing the importance of longitudinal designs and accounting for recent exposures.

RevDate: 2026-09-03

Wang L, Zhang Y, Li W, et al (2026)

Mulberry-derived endophytic Bacillus velezensis suppresses gray mold and promotes mulberry growth via reshaping the root metabolism and microbiome.

Journal of advanced research pii:S2090-1232(26)00701-0 [Epub ahead of print].

INTRODUCTION: Gray mold is an important fungal disease caused by Botrytis cinerea which threatens global agriculture. As chemical control faces limitations, biological control using Bacillus has gained attention for its environmental friendliness and growth promotion. However, their ecological basis and application potential in mulberry gray mold control remain insufficiently understood.

OBJECTIVE: This study aimed to evaluate the biocontrol efficacy of the mulberry derived endophytic strain Bacillus velezensis ZJU_268 and to investigate its associated effects on plant growth, root-associated microbiomes, and metabolic profiles.

METHODS: Greenhouse assays were combined with genomic and comparative genomic analyses, amplicon sequencing, non-targeted metabolomics, and functional validation of isolated microbes and metabolites to assess the effects of ZJU_268 and its cell free supernatant (CFS) on mulberry seedlings.

RESULTS: This study isolated a mulberry derived endophytic bacterium, B. velezensis ZJU_268, which exhibits strong antifungal activity and reduces the incidence of gray mold in mulberry seedlings. Whole-genome sequencing and comparative genomic analyses revealed strain-specific regions and genes associated with root colonization, stress adaptation, and antimicrobial biosynthesis. Both live cells and CFS significantly promoted seed germination, seedling growth, and biomass accumulation in a dose dependent manner. Amplicon sequencing showed that ZJU_268 and its supernatant reshaped the mulberry root microbiome, enriching beneficial bacterial and fungal taxa while reducing potentially pathogenic members. Cultivable members of the enriched microbiota displayed strong antifungal activity against B. cinerea and promoted mulberry growth. Metabolomic profiling further showed that ZJU_268 and its supernatant were associated with marked metabolic shifts in mulberry roots, accompanied by the accumulation of selected metabolites that supported the growth of representative enriched isolates.

CONCLUSIONS: This study demonstrates that ZJU_268 suppresses gray mold and promotes mulberry growth in association with direct antagonistic activity, microbiome restructuring, and holobiont-level metabolic shifts, providing a promising biological strategy for sustainable mulberry disease management.

RevDate: 2026-09-03

Liu P, Li J, Zhu C, et al (2026)

Dietary supplementation of resveratrol alters rumen microbiome and reduces urinary trimethylamine/trimethylamine N-oxide excretion in dairy cows.

Journal of dairy science pii:S0022-0302(26)03226-1 [Epub ahead of print].

Trimethylamine (TMA) is a major product of ruminal choline metabolism. Understanding the microbial pathways associated with TMA formation may provide opportunities to improve rumen fermentation efficiency and animal productivity; however, effective strategies to regulate rumen TMA production remain poorly understood. In this study, in vitro and in vivo experiments were combined to investigate the effects of resveratrol on rumen TMA production and urinary excretion in dairy cows. In vitro rumen fermentation was conducted with 4 resveratrol doses (0, 0.5, 5, and 50 mmol/L). Concentrations of TMA were significantly lower in the 5 and 50 mmol/L resveratrol treatments compared with the control (0 mmol/L). The in vivo experiment was conducted using 36 mid-lactation Holstein cows with an average days in milk (DIM) of 171 ± 7 d and an average parity of 3.2 ± 0.4. The experiment lasted for 5 weeks, consisting of a 1-week adaptation period followed by a 4-week experimental period. Cows were blocked according to parity, milk yield, and days in milk and then randomly assigned to CON (basal diet), RES2.4 (basal diet + 2.4 g resveratrol/cow/day), and RES4.8 (basal diet + 4.8 g resveratrol/cow/day). The total concentrations of TMA and trimethylamine N-oxide (TMAO) in plasma and urine were reduced in cows in the RES4.8 group. Resveratrol did not affect dry matter intake, apparent nutrient digestibility, and milk performance, but it altered rumen fermentation parameters. Resveratrol also increased serum globulin and glutathione peroxidase levels and reduced serum IL-6, malondialdehyde, and superoxide dismutase. Metagenomic analysis showed that resveratrol shifted the structure of bacterial and archaeal communities but did not affect those of protozoa and fungi. The relative abundance of Prevotella was significantly lower in the RES4.8 group, whereas Eubacterium_S and the archaeal orders Methanobacteriales, Methanomicrobiales, and Methanococcales were higher. Functional profiling showed that resveratrol did not affect the overall composition of carbohydrate-active enzymes but decreased the abundance of pathways related to oxidative phosphorylation, the tricarboxylic acid (TCA) cycle, terpenoid backbone biosynthesis, lipopolysaccharide synthesis, and phenylpropanoid biosynthesis. Collectively, these findings provide new insights into the mechanisms underlying resveratrol-mediated regulation of rumen function and host TMA/TMAO metabolism.

RevDate: 2026-09-03

Ahamba IS, Goswami N, Kinkpe L, et al (2026)

Host genetic and gut microbiota interactions regulating intramuscular fat deposition in livestock: mechanistic insights and implications for meat quality.

Animal bioscience pii:ab.260478 [Epub ahead of print].

Intramuscular fat (IMF) is a major determinant of meat quality, influencing tenderness, juiciness, flavor, oxidative stability, and nutritional value in livestock products. Increasing evidence indicates that IMF deposition is regulated by complex interactions between host genetics and gut microbial metabolism. This review summarizes current advances in the molecular and metabolic mechanisms linking host genetics and gut microbiota to IMF accumulation and meat quality traits. At the host level, IMF deposition is regulated by coordinated adipogenic networks involving PPARγ-C/EBPα signaling, lipogenic regulators, nutrient-sensitive pathways, and epigenetic modifications that control adipocyte differentiation and lipid storage. In parallel, the gut microbiota acts as an important metabolic regulator by producing bioactive metabolites, including short-chain fatty acids and secondary bile acids, which influence adipogenesis, inflammation, nutrient partitioning, and metabolic flexibility. Emerging evidence further demonstrates that microbial metabolites can modulate host transcriptional and epigenetic programs, thereby linking microbial activity with tissue-specific lipid metabolism. Integrative multi-omics approaches are increasingly revealing the mechanistic basis of host-microbiome interactions underlying variation in carcass composition and meat quality across livestock species. This review further highlights the translational potential of precision nutrition, microbiome modulation, and microbiome-informed breeding strategies for sustainable meat production.

RevDate: 2026-09-03
CmpDate: 2026-09-03

Feng G, Bayinbate B, Huang D, et al (2026)

Unraveling the mechanisms of flavor improvement in salt-reduced dry fermented sausages: Insights from yeast-modulated microbial interactions.

Food research international (Ottawa, Ont.), 243(Pt 1):120265.

The present study investigated the modulatory effects of Candida zeylanoides AKS6 and Debaryomyces hansenii AKS44 on the quality profile attributes of reduced-NaCl fermented sausages. Results indicated that yeast inoculation decreased pH, moisture content and water activity of reduced-NaCl fermented sausages, establishing a foundation for enhanced microbial safety. Microbiome analysis revealed that the inoculated strains dominated the fungal community, exerting competitive exclusion against endogenous undesirable fungi (e.g., Trichosporon), while synergistically promoting beneficial lactic acid bacteria such as Latilactobacillus and Weissella. Volatile profiling demonstrated that NaCl reduction induced severe flavor defects. Yeast inoculation reduced formic acid content and mitigated lipid oxidation. Furthermore, driven by enhanced microbial esterification, the synthesis of fruity esters was promoted. This microbial restructuring drove the flavor improvement: suppression of off-flavor fungi combined with lactic acid bacteria-mediated ester biosynthesis enriching the fruity ester profile. Specifically, the odor activity value of methyl hexanoate significantly increased, becoming the dominant aroma contributor. These findings highlight the remarkable potential of C. zeylanoides AKS6 and D. hansenii AKS44 as starter cultures to reconstruct the microbial metabolic network and rescue the flavor quality of low-sodium fermented meat products.

RevDate: 2026-09-03
CmpDate: 2026-09-03

Li Z, Guo Y, Zhang X, et al (2026)

Integrated microbiome and metabolome analysis reveals microbial and metabolic dynamics associated with goose foie gras spoilage during refrigerated storage.

Food research international (Ottawa, Ont.), 243(Pt 1):120303.

Goose foie gras spoils rapidly under refrigeration, yet its microbial and metabolite dynamics during storage are poorly described. Samples from a single Landes production batch were stored at 4 °C in air-sealed polyethylene pouches and analysed on days 0, 2, 4, 6, 8, 10 and 12. Three biological replicates per time point were processed for total viable count (TVC), total volatile basic nitrogen (TVB-N), thiobarbituric acid reactive substances (TBARS), 16S ribosomal RNA (rRNA) amplicon sequencing, and ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS)-based untargeted metabolomics. TVC increased from 3.85 to 6.16 log CFU/g, TVB-N from 8.99 to 27.77 mg/100 g and TBARS from 0.18 to 0.72 mg MDA/kg between day 0 and day 12, with the steepest changes appearing after day 6. The maximum TVC reached 6.16 log CFU g[-1] on day 12, below the 7 log CFU g[-1] level cited for some meat products; no sensory evaluation was performed. The late storage period is therefore described as a phase of concurrent rises in TVC, TVB-N and TBARS rather than as a confirmed spoilage endpoint. The 14 most abundant genera were retained for multivariate analysis. Seven genera, including Brochothrix, Pseudomonas, Lactobacillus and Lactococcus, met the operational definition of candidate spoilage-associated taxa. Forty candidate metabolites were screened by random forest. Five (tyramine, 4-hydroxyphenylacetaldehyde, adenosine monophosphate, oxidized glutathione and γ-glutamylcysteine) were prioritized on the joint basis of random forest importance, Benjamini-Hochberg-adjusted Kruskal-Wallis p < 0.05, ROC AUC ≥ 0.85 and KEGG pathway interpretability. Microbe-metabolite co-variation was quantified through Benjamini-Hochberg-adjusted Spearman correlation, yielding 108 microbe-metabolite pairs at BH-adjusted P < 0.05 (|ρ| ≥ 0.6), and canonical correlation analysis explained 73.39% of the joint cross-covariance in the first two variates. This study establishes a quantitative microbial-metabolic deterioration signature for refrigerated goose foie gras under air-sealed storage, provides a set of biomarker candidates with defined ROC performance, and identifies shifts in specific tyrosine, glutathione, purine and phospholipid pathways. The concordance between microbial succession and these pathway changes is hypothesis-generating and requires metagenomic confirmation, and these findings are presented as preliminary biochemical anchors for future targeted validation and preservation research.

RevDate: 2026-09-03
CmpDate: 2026-09-03

Fu C, Ye K, Qiu Z, et al (2026)

Agaricus bisporus polysaccharides alleviate high-fat diet-induced cognitive impairment via microbiota-gut-brain axis modulation.

Food research international (Ottawa, Ont.), 243(Pt 1):120317.

This study aimed to explore the protective effect of Agaricus bisporus polysaccharide (ABP) against high-fat diet (HFD) induced cognitive impairment (CI), with a particular focus on gut-brain communication. ABP supplementation alleviated anxiety-like behavior and cognitive deficits in HFD-fed mice. These effects were associated with enhanced hippocampal synaptic plasticity and attenuated inflammatory responses, which were accompanied by the elevation of Bdnf levels and the upregulated expression of plasticity-related genes (e.g., Gria2, Grin2b, Tdp2, and Fxr1). Crucially, ABP supplementation was associated with alleviated HFD-induced morphological changes in microglia and reduced inflammatory factor mRNA levels (Tnf, Il1b). Meanwhile, ABP remodeled the gut microbiome, significantly enriching beneficial taxa including Akkermansia and Bacteroides and enhancing the production of short-chain fatty acids (SCFAs), mainly acetate and propionate. These findings suggest that ABP may serve as a promising nutritional component for alleviating diet-related CI with effect associated with modulation of the microbiota-gut-brain axis.

RevDate: 2026-09-03
CmpDate: 2026-09-03

Vykypělová M, Khrapova V, O Adamovský (2026)

Microplastic in human body - a critical insight into current microplastic research.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 39(Supplementum 1):58-62.

BACKGROUND: Microplastics and nanoplastics are ubiquitous environmental contaminants, and human exposure via ingestion and inhalation is increasingly recognized. Numerous studies report microplastics in human tissues and biological fluids, yet the biological relevance and robustness of these findings remain uncertain. This critical work evaluates current evidence on microplastics in the human body, focusing on exposure pathways, particle size relevance, and analytical limitations. Mechanistic data indicate that translocation across intestinal and pulmonary barriers is likely restricted to small microplastics (< 10 µm) and nanoplastics, raising questions about reports of larger particles in human tissues. Key challenges include secondary contamination, size-dependent detection limits, and methodological artifacts associated with common analytical techniques. Experimental evidence for biological effects, including inflammation, microbiome disruption, and cancer-related pathways, is discussed in the context of physiological relevance.

AIM: Overall, our work highlights the need for standardized analytical methods, rigorous quality control, and mechanistic studies using realistic exposure scenarios to support sound microplastics related human health research.

RevDate: 2026-09-03
CmpDate: 2026-09-03

Budinská E (2026)

Microbiome in early cancer detection - biomarker potential and limitations.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 39(Supplementum 1):63-66.

BACKGROUND: Microbiome analysis in cancer research has experienced a surge in interest comparable to the introduction of microarrays for tumor gene expression profiling 25 years ago. Associative studies investigating the composition of the microbiome in stool, tumor tissue swabs and tumor biopsies of oncology patients have been conducted across most cancer types, and their number continues to grow. Screening approaches based on non-invasive or minimally invasive sampling, including the analysis of stool, saliva, urine, and buccal and rectal swabs, are from a clinical perspective among the most promising, owing in part to simpler logistics and the possibility of repeated sampling. These types of specimens are commonly used in microbiome studies, making the microbiome an attractive target for both screening and diagnostic applications.

AIM: This review aims to summarize current knowledge regarding the potential of the microbiome in the early detection of cancer, emphasizing its clinical applicability and limitations in the context of population-based prevention.

RevDate: 2026-09-03
CmpDate: 2026-09-03

Bořilová Linhartová P, D Száraz (2026)

Probiotics, postbiotics, and synbiotics in the prevention of oncological diseases.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 39(Supplementum 1):67-71.

BACKGROUND: In the context of oncological diseases of (not only) the gastrointestinal tract and the oral cavity, the role of microorganisms is being increasingly discussed and investigated. A growing body of evidence supports the significance of specific microbial strains and their products both in the etiopathogenesis of certain cancers and in their prevention and therapy.

AIM: This review summarizes recent findings on the targeted modulation of the human microbiota using probiotics (including Bifidobacteria, Lactobacilli, etc.), their products (postbiotics, e. g. butyrate), and formulations combining probiotics with prebiotics (synbiotics), in the context of cancer prevention and progression, adverse effects of anticancer therapy, and associated complications related to the disease and surgical treatment. The results of clinical studies demonstrate the benefits of these preparations, particularly in preventing and alleviating gastrointestinal symptoms and postoperative infectious complications, as well as inflammatory mucosal damage (including oral mucositis) in oncology patients, with multi-strain probiotic formulations demonstrating greater efficacy. Research is even underway in animal models to explore the use of probiotics in immunotherapy. Despite the promising results obtained from modulating the human microbiota to improve the quality of life of cancer patients, as well as for cancer prevention and potentially even therapy, broader clinical implementation is limited by interindividual variability of the microbiome, safety concerns in immunocompromised patients, and the insufficiently documented quality of some available products. Nevertheless, given the undeniable mechanistic and translational potential of probiotic, postbiotic, and synbiotic supplementation, continued clinical research in this field is highly warranted.

RevDate: 2026-09-03

Subrahmanian A, Patel A, Veerus L, et al (2026)

Methanogens: vital but threatened members of the human microbiome?.

Trends in microbiology pii:S0966-842X(26)00224-6 [Epub ahead of print].

Methanogens are an ancestral group of archaea that occupy a unique niche within the human gut microbiome by virtue of their methane production. In this process, they serve as hydrogen sinks, allowing continued bacterial fermentation and influencing short-chain fatty acid production. Available evidence suggests that methanogen abundance may be declining in parallel with the broader reduction in gut microbial diversity accompanying industrialization. We describe the evolution of methanogens, their ecological roles in the human microbiome, and evidence for their apparent decline. If confirmed, reductions in methanogen prevalence and abundance may have substantial metabolic consequences, reframing these archaea as keystone species in need of scientific attention and conservation efforts.

RevDate: 2026-09-03

Hejndorf S, Gulay A, Zheng C, et al (2026)

The Relationship Between the Preoperative Gut Microbiome and Systemic Inflammatory Response Syndrome After Cardiac Surgery: A Prospective Cohort Study.

Journal of cardiothoracic and vascular anesthesia pii:S1053-0770(26)00785-8 [Epub ahead of print].

OBJECTIVES: To determine whether preoperative intestinal microbiome characteristics are associated with the development of systemic inflammatory response syndrome (SIRS) after cardiac surgery.

DESIGN: Single-center prospective observational cohort study.

SETTING: Tertiary university hospital.

PARTICIPANTS: A total of 196 adults undergoing elective cardiac surgery with extracorporeal circulation between 2018 and 2019.

INTERVENTIONS: No microbiome-targeted intervention was performed.

MEASUREMENTS AND MAIN RESULTS: Shotgun metagenomic sequencing was used to assess microbial diversity (inverse Simpson index, gene richness, dominance), taxonomic composition, and functional potential. The primary outcome was development of SIRS within 24 hours postoperatively. Associations were evaluated using Wilcoxon rank-sum tests, χ[2] tests, and logistic regression adjusted for age and sex. Forty-four patients (22%) developed SIRS. Microbiome diversity did not differ significantly between patients with and without SIRS (median inverse Simpson index 20.4 v 19.3, p = 0.12; gene richness, p = 0.30; dominance, p = 0.61). In adjusted analyses, diversity was not associated with SIRS risk (odds ratio, 1.04; 95% confidence interval, 0.99-1.07). Descriptive analyses of taxonomic composition and functional potential similarly revealed no significant differences between SIRS and non-SIRS groups.

CONCLUSIONS: In this cohort of elective cardiac surgery patients, preoperative gut microbiome diversity, composition, and functional potential were not associated with the development of postoperative SIRS. These findings do not support a strong causal or predictive role of the presurgical gut microbiome in postoperative inflammatory responses after cardiac surgery.

RevDate: 2026-09-03

Pushpakumara BLDU, Coffey MJ, Hudson J, et al (2026)

The cystic fibrosis gut microbial dysbiosis index (CF-GMDI): a quantitative measure of gut microbial imbalance in children with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society pii:S1569-1993(26)03721-5 [Epub ahead of print].

BACKGROUND: Gut dysbiosis is a hallmark of cystic fibrosis (CF), typically characterised using non-specific diversity metrics and study-specific taxonomic lists, limiting comparability across studies. We aimed to develop a metagenomic, species-level CF Gut Microbial Dysbiosis Index (CF-GMDI) to standardise measurement of gut microbial imbalance in children with CF (cwCF) METHODS: CF-GMDI was derived using stool metagenomic data from the PEARL-CF study (70 cwCF; 67 healthy controls (HC); 0-6 years). Differentially abundant taxa were identified between cwCF and HC using MaAsLin2. The index was calculated as the log10 ratio of the summed relative abundances of taxa enriched in CF vs HC to those depleted in CF vs HC. Reproducibility was assessed in the independent EARTH cohort (56 cwCF; 56 HC; 0-18 years). Responsiveness to therapy was evaluated using publicly available metagenomic data from an Elexacaftor/Tezacaftor/Ivacaftor (ETI) study (39 cwCF; 6-18 years).

RESULTS: CF-GMDI was significantly higher in cwCF than HC (p < 0.001), inversely correlated with species richness (ρ = -0.74, p < 0.001), and higher in pancreatic-insufficient vs pancreatic-sufficient cwCF in the PEARL-CF cohort (p = 0.01). Key ecological and clinical associations were replicated in the EARTH cohort. In the ETI study, CF-GMDI decreased significantly at 6 and 12 months post-treatment, whereas alpha diversity remained unchanged.

CONCLUSIONS: CF-GMDI is a CF-associated metric that captures clinically relevant gut microbiome restructuring not detected by standard diversity measures in cwCF (0-18 years). It differentiates disease and pancreatic status and tracks therapeutic modulation, supporting its use as a novel endpoint in CF intervention studies.

RevDate: 2026-09-03
CmpDate: 2026-09-03

Nan YQ, Wei LW, Chen RN, et al (2026)

[Role of bidirectional interaction between TCM and gut microbiota in treatment of osteoporosis].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 51(16):4581-4593.

With the progressive aging of the population in China, the incidence of osteoporosis(OP) is rising annually. This condition not only severely impacts patients' quality of life but also imposes a substantial economic burden on both families and the society. Although modern western medicine has achieved progress in inhibiting OP progression and alleviating associated clinical symptoms, its overall therapeutic efficacy remains suboptimal due to issues such as adverse drug reactions and patient tolerance. Consequently, developing efficient, safe, and cost-effective prevention and treatment strategies has become an urgent priority in current OP-related clinical and scientific research. In recent years, growing insights into the microbiome have revealed that the gut microbiota can regulate bone quantity and quality through multiple mechanisms, including immune modulation, calcium and phosphorus absorption, and the production of short-chain fatty acids, thereby improving the bone microenvironment. As an important component of traditional medicine, TCM is characterized by multi-component and multi-target effects, with therapeutic advantages in holistic regulation. Studies have shown that TCM can effectively improve bone mineral density, inhibit bone resorption, and promote bone formation, with a low incidence of adverse reactions and mild pharmacological effects, demonstrating its unique clinical value in the prevention and treatment of OP. Simultaneously, complex interactions exist between TCM and the gut microbiota. On the one hand, the active components of TCM can modulate the composition and structure of the gut microbiota, reduce systemic inflammation, and ultimately improve bone metabolism. On the other hand, the gut microbiota can metabolize and transform the active components of TCM, enhancing their bioavailability and promoting therapeutic efficacy. This article systematically reviews the roles of gut microbiota and TCM in OP, as well as the bidirectional interaction between TCM and gut microbiota in the prevention and treatment of OP, aiming to provide new insights and evidence for the clinical management of OP.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Berto LP, Ding J, Sakae LO, et al (2026)

Effect of a sodium fluoride rinse on the composition of early oral biofilms formed in situ on enamel and dentine.

Clinical oral investigations, 30(9):.

OBJECTIVES: Dental caries results from dysbiotic shifts in the microbial community, so modulating biofilm composition represents a valid preventive strategy. The aim of this double-blind randomized crossover in situ study was to investigate how a fluoride rinse can modify the composition of the early oral biofilm formed on enamel and dentine.

MATERIALS AND METHODS: Twelve volunteers wore mandibular appliances containing 3 enamel and 3 dentine specimens for 1 min, to allow basal pellicle formation, then rinsed (1 min) with a NaF solution (500 ppm F⁻) or deionized water (DW) and kept the appliance overnight (8 h). The composition of the biofilms was analysed using full-length 16 S rRNA gene sequencing.

RESULTS: Alpha and beta diversity did not differ between groups. Dominant genera were Streptococcus (61-71%), Haemophilus (15-24%), Gemella (4-6%), Veillonella (1-3%), and Rothia (1-2%), with no significant group differences. On both enamel and dentine, NaF rinse significantly increased the relative abundance of several Streptococcus spp., including S. salivarius and S. toyakuensis, while decreasing species of Streptococcus, Neisseria, and Prevotella. On enamel, NaF reduced S. gordonii and increased S. oralis and S. parasanguinis; on dentine, it increased species of Rothia and Haemophilus.

CONCLUSIONS: NaF rinse induces subtle species-level changes in early biofilms formed on enamel and dentine, while overall community diversity and dominant genera remain stable.

CLINICAL RELEVANCE: This exploratory study suggests that a 500 ppm NaF rinse is associated with subtle species-level shifts in early oral biofilms. Further studies are needed to determine whether these changes translate into functional benefits or improved oral health outcomes.

CLINICAL TRIAL REGISTRATION: The study protocol was registered at ClinicalTrials.gov (NCT04033263).

RevDate: 2026-09-04

Zhao Q, Hu X, Zeng X, et al (2026)

Effects of Continuous Cropping on Chili Root Rot: Insights from Rhizosphere Microbial Communities and Synthetic Community Applications.

Plant disease [Epub ahead of print].

Continuous cropping often results in stunted plant growth and a higher incidence of soil-borne diseases. Soil microbial communities play a crucial role in promoting plant growth, maintaining plant health, and enhancing plant resistance to various diseases. This study examines the impact of continuous cropping on chili root rot and explores the contribution of soil microbial communities to alleviating this issue. The results revealed that prolonged continuous cropping significantly altered the composition of the rhizosphere bacterial community. High-throughput sequencing analysis indicated a marked increase in the abundance of Fusarium pathogens, accompanied by a significant decline in antagonistic bacteria from the genera Bacillus and Pseudomonas. LEfSe analysis showed that Bacillus and Pseudomonas were the core bacterial biomarkers in chili continuous cropping soil, which were successfully isolated and demonstrated significant antagonistic effects against Fusarium solani. Utilizing these antagonistic bacteria, nine different synthetic communities (SynComs) were constructed. Among them, the T7 SynCom exhibited excellent biocontrol efficacy. It effectively suppressed the pathogen, reduced the incidence of root rot, and enhanced systemic induced resistance by activating the plant immune-associated pathways, including the MAPK signaling pathway, ethylene signaling pathway, and pathways mediated by jasmonic acid and salicylic acid. These findings offer new insights into using functional SynComs as a sustainable agricultural solution and open new avenues for overcoming the challenges posed by continuous cropping.[Formula: see text] Copyright © 2026 The Author(s). This is an open access article distributed under the CC BY 4.0 International license.

RevDate: 2026-09-04

Liu C, Wang J, Liaw A, et al (2026)

Salivary Extracellular Vesicles from Host, Bacteria and Fungus as Nanomessengers Reflecting Host-Microbiome Interaction in Periodontal Inflammation.

ACS applied materials & interfaces pii:5416617 [Epub ahead of print].

Extracellular vesicles (EVs) secreted by the host and polymicrobial oral community are natural endogenous biological nanoparticles that mediate host-microbe interactions. Given their abundance in biofluids, host, fungal and bacterial EVs circulating in saliva may reflect periodontitis-associated microbial dysbiosis and inflammation. In this study, salivary EVs from 20 healthy controls and 57 stages III/IV periodontitis were isolated using a dual strategy: immunoaffinity to isolate host EVs for cytokine profiling, followed by size-exclusion chromatography (SEC) to enrich non-host (microbial) EVs for 16S rRNA and fungal ITS sequencing. In periodontitis, we observed a significant increase in CD49e+ and CD105+ host EV subpopulations and elevated host EV-associated cytokines of tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor (GM-CSF), indicating an enhanced inflammatory host-EV profile. 16s rRNA sequencing of non-host microbial EV-DNA profiling revealed enrichment of bacterial EVs (BEVs), including genera Porphyromonas, Treponema, Filifactor, and Tannerella, with species of Porphyromonas gingivalis, Filifactor alocis, Tannerella forsythia, Treponema denticola, and Treponema socranskii. In contrast, commensal genera BEVs (Neisseria, Haemophilus) and fungal EVs from Malassezia globosa were enriched in health. Fungal EVs from Candida albicans and M. arunalokeiwere also elevated in disease. Combined host-EVs-IL-9 and T. forsythia-BEVs achieved an AUC of 0.989, increasing to 0.992 with the addition of F. alocis-BEVs, outperforming individual markers (AUC = 0.85-0.91). Pooled periodontitis microbial EVs (10 µg/mL) induced a proinflammatory response in the oral keratinocytes (OKFs) after 24 h, with increased IL-6 and IL-8 cytokines, and upregulated mRNA expression of C-C motif chemokine ligand 2 (CCL2), IL-1β, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) compared with the no-EV control. Our findings demonstrated that salivary host-, bacterial-, and fungal-derived salivary EVs act as natural nanomessengers reflecting host-microbiome interactions and represent promising non-invasive candidate biomarkers of periodontitis.

RevDate: 2026-09-04

Lorefice L, Fenu G, Fantola G, et al (2026)

Ultra-processed foods and multiple sclerosis: Evidence, pitfalls and perspectives.

Multiple sclerosis (Houndmills, Basingstoke, England) [Epub ahead of print].

Ultra-processed foods are increasingly recognised as drivers of adverse health outcomes, yet their implications for multiple sclerosis remain underexamined. Emerging evidence suggests that ultra-processed food-rich dietary patterns are associated with greater central adiposity, pro-inflammatory metabolic signatures, microbiota disruption and adverse neuroimmune profiles relevant to multiple sclerosis. Major conceptual pitfalls, including the heterogeneity of ultra-processed foods and the scarcity of longitudinal or interventional studies addressing neuroimmune outcomes, continue to limit interpretation. Ultra-processed food-driven comorbidities, such as obesity, hypertension, dyslipidaemia, insulin resistance and depression, may further accelerate disability accumulation and reduce treatment efficacy in multiple sclerosis, underscoring the need for integrated dietary-immune models. This review integrates evidence from epidemiology, mechanistic studies, microbiome research and exposome science to provide a coherent framework for interpreting ultra-processed food-multiple sclerosis interactions. Recognising ultra-processed food exposure as a potentially modifiable contributor to multiple sclerosis activity may inform future preventive and therapeutic strategies.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Sun W, Wang Y, Zhang X, et al (2026)

Dietary tryptophan ameliorates metalaxyl-induced colitis by restoring microbial tryptophan metabolism and aryl hydrocarbon receptor activation.

Frontiers in nutrition, 13:1930000.

INTRODUCTION: The extensive production of environmental pollutants has heightened susceptibility to intestinal disorders, potentially through alterations in the gut microbiota. However, the precise role of the gut microbiota in environmental pollutant-induced inflammation remains incompletely understood.

METHODS: In this study, wild-type and IL-10[-/-] mice were employed to simulate the responses of healthy individuals and those genetically predisposed to inflammatory bowel disease (IBD) to environmental toxicants. Mice were exposed to metalaxyl, and an integrated multi-omics approach combining microbiome and metabolome profiling with machine learning was conducted to investigate the underlying mechanisms. Additionally, dietary tryptophan supplementation was administered to evaluate its protective effects.

RESULTS: Metalaxyl exposure induced low-grade colonic inflammation in wild-type mice and triggered severe colitis in IBD-susceptible mice. Multi-omics analysis revealed that metalaxyl significantly disrupted gut microbial composition, reduced the synthesis of endogenous tryptophan-derived metabolites, and inhibited aryl hydrocarbon receptor (AhR) signaling, ultimately initiating intestinal barrier dysfunction and inflammatory cascades. Notably, dietary tryptophan restored gut tryptophan metabolite levels, strengthened AhR signaling, mitigated intestinal inflammation, and repaired barrier defects.

DISCUSSION: This study identifies the gut microbiota as a central mediator of environmental pollutant-induced IBD and demonstrates that a high-tryptophan diet exerts beneficial effects against environmental colitis via the AhR axis. Furthermore, the stable phenotypes and high reproducibility of this dual-genotype mouse model underscore its utility as an ideal platform for investigating the enterotoxic effects of environmental pollutants.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Maslov DE, Osipov ID, Zabelina DS, et al (2026)

Molecular epidemiology of respiratory viral infections in hospitalized children in Novosibirsk, Russia, 2021-2023.

Frontiers in pediatrics, 14:1882419.

BACKGROUND: Acute respiratory infections (ARIs) are among the leading global causes of morbidity and mortality in children. While viral agents of ARI are rigorously monitored, other pathogenic organisms and pathobionts - bacteria and fungi native to the host microbiome - remain largely neglected. Adenoviral types also warrant particular attention especially given the widespread use of adenoviral vector vaccines during the COVID-19 pandemic.

METHODS: Oro-nasal swabs collected from 1679 children under the age of 18 hospitalized in Novosibirsk, Russia between February 2021 and June 2023, were tested for the presence of nucleic acids by the diagnostic panel targeting 17 viruses, 12 bacteria and one yeast. Adenovirus-positive samples were additionally fine-typed by Sanger sequencing.

RESULTS: Overall, 79.15% of samples were positive for at least one of 17 viral pathogens, with RSV (22.87% positives) and RhV (24.54% positives) dominating the etiological structure. Oro-nasal presence for respiratory pathobionts and opportunistic pathogens was 67.96% and 11.49%, respectively. Generally, viral seasonality was typical for continental climate, with only two notable deviations: MpV absence in spring of 2022 followed by earlier December peaks in the same year; an earlier RSV maximum in October 2021 with extended circulation the next epidemic season. Overall, the epidemiology of the analyzed viruses was consistent with worldwide surveillance trends and largely stable between the two later epidemic seasons. In viral-bacterial association analysis we identified two significantly attracted pairs, in which virus is known to facilitate bacterial adherence to respiratory epithelium. Adenovirus fine-typing provided preliminary evidence that serotypes 1, 2, 3, and 7 are the most frequently detected among the typed samples, while vaccine serotype AdV-5 was identified in only two cases.

CONCLUSION: Broad target coverage allowed for a comprehensive analysis of epidemiological patterns, highlighting a trend toward stabilization of the etiological structure to pre-pandemic levels, and allowed for prioritization of clinically relevant viral-bacterial associations. Preliminary findings in adenoviral fine-typing are consistent with global trends in serotype prevalence and help address an important gap in regional adenoviral epidemiology.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Mojsak P, Zmyslowska-Polakowska E, Chmielewska S, et al (2026)

Integrated Oral Microbiome and Metabolome Profiling Identifies Disease-Associated Multi-Omics Signatures in Alström and Bardet-Biedl Syndromes.

Computational and structural biotechnology journal, 35(1):0211.

Background: Alström syndrome (ALMS) and Bardet-Biedl syndrome (BBS) are rare ciliopathies characterized by multisystem involvement, including obesity, insulin resistance, and type 2 diabetes. Systemic metabolic dysfunction may influence the oral microbiome; however, integrative analyses that combine microbial and metabolic profiles in these disorders remain limited. Methods: Saliva and gingival crevicular fluid (GCF) samples were collected from genetically confirmed ALMS and BBS patients, as well as from obesity and healthy control groups. Microbial communities were profiled using V3-V4 16S rRNA gene amplicon sequencing, and untargeted metabolomic profiling was performed by gas chromatography-mass spectrometry. Microbiome-metabolome associations were evaluated using Spearman's rank correlation analysis, followed by multi-omics integration using Multiple Co-Inertia Analysis (MCIA) and the supervised Data Integration Analysis for Biomarker discovery using Latent cOmponents (DIABLO) framework (mixOmics). Results: Integrated analysis identified distinct microbiome-metabolome association patterns in ALMS and BBS. Compared with controls, the ALMS+BBS group showed enrichment of Prevotella, Enterococcus, and Eikenella, alongside reduced Lactobacillus abundance. Metabolomic profiling revealed alterations in amino acid, fatty acid, and carbohydrate metabolism. GCF exhibited structured associations between metabolites and Firmicutes, Proteobacteria, and Actinobacteriota, whereas saliva showed broader interaction networks. These associations were absent or markedly weaker in obesity and healthy controls. MCIA demonstrated coordinated variation across the oral microbiome, salivary metabolome, and GCF metabolome, while DIABLO identified a shared multi-omics signature. Conclusions: Coordinated shifts in amino acid, lipid, and central carbon metabolism can be linked to oral microbial reorganization in ALMS and BBS. Integrative multi-omics analyses identified coordinated microbiome-metabolome signatures across the oral microbiome, saliva, and GCF. These findings warrant validation in larger longitudinal and functional studies.

RevDate: 2026-09-04

Das M, Thajuddin N, Muralitharan G, et al (2026)

From Gut to Mind: Impact of Probiotics on Depression, Anxiety, Mood, Gut Microbiota, Sleep and Stress-A Systematic Review of RCTs.

Annals of neurosciences [Epub ahead of print].

BACKGROUND: Probiotic supplementation may influence mental health through the gut-brain axis, with potential effects on depression, anxiety, sleep, cognition, stress hormones, and gut microbial composition. This systematic review aimed to evaluate the effects of probiotics on psychological, physiological, and gut microbiome-related outcomes across diverse populations.

SUMMARY: A comprehensive search of PubMed, MEDLINE, PsycINFO, and ScienceDirect identified randomized controlled trials evaluating probiotic supplementation. Twenty RCTs were included, of which 15 were assessed as having a low risk of bias and five as having a high risk of bias. Commonly assessed outcomes included depression (n = 17), anxiety (n = 10), sleep quality (n = 9), stress (n = 6), cortisol (n = 7), cognitive function (n = 5), quality of life (n = 5), gut microbial composition (n = 11), and other neuroendocrine and inflammatory markers. Overall, probiotics were associated with improvements in depression, anxiety, sleep quality, mood, cognition, quality of life, and beneficial gut microbial populations, although findings for cortisol and stress-related outcomes were inconsistent.

KEY MESSAGE: Probiotic supplementation may provide beneficial effects on psychological well-being and gut microbial composition. However, heterogeneity among interventions, populations, outcome measures, and study quality warrants further well-designed RCTs.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Chen L, Ye L, Li X, et al (2026)

The relationship between C. psittaci infection and respiratory failure based on respiratory microbiota analysis: a retrospective cohort study.

Frontiers in medicine, 13:1899239.

OBJECTIVES: This study aimed to explore the impact of the pulmonary microbiota on the occurrence of respiratory failure in patients with psittacosis pneumonia.

METHODS: A total of 20 patients diagnosed with psittacosis pneumonia were enrolled in this study. Patients were divided into two groups according to the presence or absence of respiratory failure at admission. Clinical data, laboratory findings, and bronchoalveolar lavage fluid analyses were collected. Next-generation sequencing was employed to analyze the pulmonary microbiota.

RESULTS: In this cohort, patients with respiratory failure exhibited a significantly higher relative abundance sequences of C. psittaci compared with those without respiratory failure. Notably, Spearman correlation analysis indicated a significant negative correlation between C. psittaci relative abundance of sequences and CD4+ T-lymphocyte counts (r = -0.870, p = 0.002) and a positive correlation with the pulmonary arteriovenous oxygen partial pressure difference (r = 0.728, p = 0.017). Further analysis of the bacterial communities showed a negative association between Pseudomonas and C. psittaci (r = -0.509, p = 0.031), whereas Veillonella was positively correlated with C. psittaci (r = 0.533, p = 0.023).

CONCLUSIONS: The relative abundance sequences of C. psittaci was significantly higher in patients with respiratory failure than in those without respiratory failure, suggesting an association between C. psittaci load and disease severity. The significant negative correlation between relative abundance sequences of C. psittaci and CD4+ T-lymphocyte count suggests that C. psittaci may exacerbate disease progression by compromising the host immune response, but direction of this relationship cannot be determined. Furthermore, the negative correlation between the relative abundance sequences of Pseudomonas and C. psittaci suggests a possible competitive or protective interaction between these two organisms. In contrast, the positive correlation between Veillonella and C. psittaci may indicate a shared ecological niche. These findings provide preliminary evidence of a relationship between lung microbiota composition and the severity of psittacosis pneumonia, while the causal mechanisms remain to be elucidated in future studies.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Putignani L, Marsiglia R, Turco L, et al (2026)

The gut reservoir of carbapenem-resistant Enterobacterales: from dysbiosis and colonization to infection and decolonization, with a focus on patients with hematologic malignancies - a narrative review.

Frontiers in cellular and infection microbiology, 16:1939690.

Carbapenem-resistant Enterobacterales (CRE) remain among the highest-priority antimicrobial-resistant pathogens worldwide, and intestinal colonization is increasingly recognized as the key precursor of invasive infections, particularly in patients with hematological malignancies. Increasing evidence indicates that disruption of the gut microbial ecosystem, reflected in reduced diversity, depletion of beneficial anaerobic taxa, intestinal barrier dysfunction, immune dysregulation, and expansion of Enterobacterales, plays a central role in the transition from colonization to infection. Consequently, restoring colonization resistance through microbiome-targeted interventions has emerged as a promising preventive strategy. This narrative review summarizes the current evidence on the epidemiology and clinical impact of CRE colonization and infection, with particular emphasis on the ecological alterations of the gut microbiome linking gut dysbiosis to epithelial barrier dysfunction, immune dysregulation, and loss of colonization resistance to CRE persistence and invasive infection. We critically discuss both conventional and emerging decolonization approaches, including selective digestive decontamination, probiotics, prebiotics and synbiotics, fecal microbiota transplantation (FMT), bacteriophage therapy, and CRISPR-Cas-based technologies, highlighting their mechanisms of action, available clinical evidence, and current limitations. Particular attention is given to patients with hematological malignancies, in whom the clinical need for effective decolonization strategies is greatest. Although FMT currently represents the most promising microbiome-based intervention, the available evidence remains heterogeneous and largely derived from small studies. Overall, durable and standardized decolonization strategies have yet to be established, underscoring the need for well-designed multicenter randomized clinical trials to define effective microbiome-directed approaches for preventing CRE-related infections in high-risk populations.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Ma K, Thairu M, K Sankaran (2026)

Design, processing, and modeling for longitudinal multiomics microbiome data.

Frontiers in cellular and infection microbiology, 16:1837109.

Longitudinal multiomics studies can reveal mechanisms underlying microbiome dynamics. Though gathering such data has become increasingly accessible, challenges remain in experimental design, data processing, and interaction modeling. This mini-review surveys practical approaches for analyzing longitudinal multiomics microbiome data. We provide an overview of fundamental questions these experimental designs can address, discuss concepts for reducing confounding, review tools for data management, and describe statistical and machine learning methods for identifying interactions across time and biological layers. We conclude with emerging trends and open problems.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Niu Q, Mu T, Zhang J, et al (2026)

Gastrointestinal motility in microgravity: a critical review of multi-level mechanisms and model-dependent effects.

Frontiers in physiology, 17:1930628.

BACKGROUND: Gastrointestinal motility disturbances rank among the most frequently reported medical complications of spaceflight. Astronauts experience delayed gastric emptying, erratic small intestinal transit and reduced colonic propulsion. The underlying mechanisms are multifactorial. Microgravity alters intra-abdominal physical mechanics, disrupts autonomic and enteric neural circuits, shifts gastrointestinal hormone secretion profiles, inflicts oxidative stress upon effector cells, and perturbs gut microbial communities. Cross-model comparisons reveal substantial disagreement, suggesting that no single ground-based analog fully captures the pathophysiology of orbital flight.

AIM: To critically review how weightlessness affects gastric emptying, small intestinal transit and colonic motility; to critically evaluate contradictory findings across simulation platforms; and to delineate the neural, humoral, cellular and microbiological mechanisms involved.

METHODS: We searched PubMed, Web of Science and the NASA Technical Reports Server for articles published between January 1990 and June 2026 (last search 30 June 2026). Search terms included: "microgravity", "weightlessness", "spaceflight", "gastrointestinal motility", "gastric emptying", "intestinal transit", "gut microbiome", "interstitial cells of Cajal" and "oxidative stress". Studies using head-down bed rest, hindlimb unloading, clinorotation, parabolic flight and actual spaceflight were included. The review follows a critical narrative design; the full search strategy and the framework used to appraise the evidence are described in Section 1.1.

RESULTS: Altered-gravity studies suggest that gastrointestinal dysmotility may involve neurohumoral dysregulation, oxidative injury to interstitial cells of Cajal and smooth muscle, barrier dysfunction and altered enteric signaling; however, most mechanistic evidence derives from simulated models and has not been directly validated during human spaceflight. Direct human motility measurements remain sparse, and the evidence comprises a mixture of direct observations, model-dependent inferences and testable hypotheses. Cross-study agreement is poor: some head-down bed rest trials report accelerated small-bowel transit, whereas tail-suspension models and limited flight observations suggest motor suppression. These divergences may reflect model-specific confounding rather than a uniform effect of microgravity.

CONCLUSION: Current ground-based models each capture only partial aspects of orbital GI pathophysiology. Future work should combine multi-omics profiling with next-generation simulation platforms to develop evidence-based countermeasures for long-duration missions.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Carvalho A, Gschwendtner S, Schloter M, et al (2026)

Stool microbiota variations along the adenoma-colorectal carcinoma sequence - robustness of disease-associated microbial features.

Frontiers in microbiology, 17:1822941.

INTRODUCTION: Colorectal cancer (CRC) has been linked with gut microbiota dysbiosis, thereby fostering the discovery of disease-associated microbial signatures. However, the use of covariate-adjusted methods accounting for confounders effects on microbiome shifts is far from being a gold standard approach, leading to spurious microbial-disease associations. This study aimed to characterize stool microbiota alterations along the adenoma-carcinoma sequence in a Portuguese cohort, and assess the robustness of candidate microbial features.

METHODS: Stool samples from healthy individuals (HC), adenoma patients (AP), and CRC patients at early (SI/II) and advanced (SIII/IV) stages, were analyzed using 16S rRNA gene amplicon sequencing. Microbial features' profiles were compared with publicly available datasets from France, Ireland, Italy, and USA/Canada. Differential abundance (DA) analysis was conducted through multiple DA models (ANCOM-BC2, fastANCOM, MaAsLin2, limma voom, and LEfSe) and statistical approaches, including covariate (age, sex, and body mass index (BMI)) adjustment, prevalence filtering, and analysis of matched subsets.

RESULTS AND DISCUSSION: Among the altered taxa along de adenoma-carcinoma sequence, Sutterella and Desulfovibrio were generally enriched across different DA tools and matched subset analyses, while Parasutterella and Adlercreutzia were depleted. Sutterella, Parasutterella, and Adlercreutzia, were already altered in adenoma and early-stage CRC samples, maintaining or increasing their effect sizes towards advanced CRC stages. This pattern highlights the potential of these taxa as early microbial signatures of colorectal cancer progression. In contrast, Fusobacterium, which is a widely accepted CRC biomarker, was not detected after covariate adjustment. Cross-cohort comparison revealed a limited reproducibility of microbial features (i.e., Dialister was enriched in the Portuguese and French cohorts; Parasutterella and Terrisporobacter were depleted in the Portuguese and USA/Canada datasets), being most of them cohort-specific.

CONCLUSION: Overall, our results strengthen the importance of covariate control towards the identification of potentially robust and reproducible microbial markers of CRC onset and progression.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Ma J, Li S, Qiao Y, et al (2026)

Context-dependent functions of the aryl hydrocarbon receptor in gastrointestinal cancers: from microenvironmental regulation to precision targeted therapy.

Frontiers in cell and developmental biology, 14:1886657.

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor with context-dependent roles in gastrointestinal (GI) tumor development. Depending on cellular context and microenvironment, AhR can preserve epithelial integrity, suppress inflammation, and inhibit tumor growth, but it can also promote immune evasion and metabolic reprogramming to drive tumor progression. Most existing reviews have focused on a single GI tumor type or functional dimension, and the concept of AhR as a context-dependent signaling hub has not been effectively linked to therapeutic stratification across the full spectrum of GI malignancies. No prior review has systematically compared AhR across five GI cancer types-esophageal, gastric, colorectal, hepatocellular, and pancreatic-or addressed the translational gap between preclinical data and clinical application. This review addresses these gaps in three key ways. First, it provides the first head-to-head comparative analysis of AhR functions across these five cancer types. Second, it adopts a functional stratification framework integrating five core mechanistic dimensions-tumor stemness, epithelial-mesenchymal transition, immune remodeling, metabolic reprogramming, and drug resistance-and proposes a three-dimensional AhR stratification model. Third, it systematically discusses emerging AhR-targeted therapeutic strategies-including antagonists, selective AhR modulators (SAhRMs), PROTACs, combination therapies, and microbiome-based interventions-while critically evaluating translational challenges. By establishing this context-informed framework, we aim to provide a conceptual basis for biomarker-guided evaluation of AhR-targeted strategies in GI cancers.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Bautista J, Iñiguez-Ramírez A, Villegas-Chávez JA, et al (2026)

Skin microbiome and cutaneous aging mechanisms and clinical implications.

Frontiers in microbiology, 17:1917816.

The skin microbiome is an integral component of the cutaneous ecosystem and contributes to barrier, immune, and metabolic homeostasis. Available evidence is examined across three distinct levels: microbial community structure, functional activity, and host biological response. This ecological-functional distinction is necessary because taxonomic abundance alone does not establish microbial activity, biological effects, or causality. Age-associated microbial variation is considered within the physiological context of cutaneous aging, including reduced sebaceous activity, altered hydration and surface pH, impaired barrier recovery, chronic low-grade inflammation, oxidative stress, and extracellular matrix deterioration. Microbial alterations reported in acne, atopic dermatitis, and rosacea further illustrate how changes in the cutaneous environment can modify host-microbiome interactions and contribute to clinically relevant phenotypes. Translational developments in dermatology and aesthetic medicine include microbiome-compatible skincare, prebiotic and postbiotic formulations, live biotherapeutic approaches, and strategies intended to preserve microbial and barrier recovery after dermatological procedures. Interpretation of the available literature remains limited by low microbial biomass, anatomical and interpersonal heterogeneity, contamination risk, differences in sampling and sequencing methods, and limited functional and longitudinal resolution. Observed microbial remodeling should be interpreted within a bidirectional host-microbiome relationship. Physiological changes that accompany aging can reshape microbial ecology, whereas microbial products may modify barrier and immune responses. Current evidence does not establish whether these microbial alterations are causes, consequences, or correlates of cutaneous aging. Integration of strain-resolved microbiome data with microbial gene expression, metabolite measurements, host molecular responses, and clinical phenotypes will be required to identify biologically relevant microbial functions and determine their value in dermatological practice.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Zhao X, Liu Z, Yang J, et al (2026)

Causal AI for cancer immunotherapy: a narrative framework review of target trial emulation, treatment-effect learning and clinical translation.

Frontiers in immunology, 17:1896755.

This narrative framework Review examines how artificial intelligence (AI) can move cancer immunotherapy research from outcome prediction toward target-trial-based treatment-effect learning. AI has produced increasingly accurate models for predicting response, survival and immune-related toxicity during cancer immunotherapy. Yet most models estimate outcome risk under observed care rather than the causal effect of choosing one strategy over another. We therefore frame immunotherapy AI as a causal digital-medicine problem: clinically useful AI should begin with a target-trial question that specifies eligibility, time zero, treatment strategies, comparators, outcomes, estimands and bias-control plans before model development. Within this framework, multimodal AI outputs from imaging, digital pathology, omics, microbiome data, electronic health records and clinical text can function as baseline confounders, candidate effect modifiers, longitudinal state variables or outcome-ascertainment tools. We distinguish established causal-inference approaches, such as target trial emulation, propensity-score weighting, g-methods, TMLE, DML and heterogeneous-treatment-effect estimation, from exploratory technologies such as reinforcement learning and digital twins that require prospective safety validation. We close by outlining validation, reporting, workflow, regulatory and lifecycle-monitoring requirements for moving from predictive biomarkers to trustworthy causal learning systems in immuno-oncology.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Shouq MI, Saleem HGM, Wang Y, et al (2026)

Lesion-specific oral microbiome signatures and predicted carcinogenic pathways in oral squamous cell carcinoma: a paired-site study in Pakistan.

Journal of oral microbiology, 18(1):2721025.

BACKGROUND: Oral squamous cell carcinoma accounts for over 90% of oral neoplasms. Despite therapeutic advances, the lack of reliable, non-invasive biomarkers and delayed diagnosis continues to impede effective clinical management. By combining paired lesion and non-lesion sampling with predictive metagenomics analysis, our study addresses this gap and advances the current understanding of microbiome‒tumor interactions.

METHODS: We analyzed 92 buccal swab samples from 39 OSCC patients and 14 healthy controls using 16S rRNA gene (V3-V4) sequencing. Taxonomic profiling was conducted using QIIME2 and SILVA/eHOMD databases, functional pathways were predicted using PICRUSt2, and hub taxa were identified through co-abundance network analysis.

RESULTS: Microbial community structure differed significantly across lesion, non-lesion, and healthy sites (PERMANOVA, p = 0.001). Lesions were enriched with Selenomonas infelix and Treponema vincentii, while healthy controls harbored Streptococcus oralis and Gemella haemolysans. Co-abundance network analysis revealed lesion-specific hub species, notably T. vincentii, strongly correlated with predicted activation of pyrimidine biosynthesis pathways (r = 0.69, q < 1E-6), suggesting predicted metabolic alterations in the tumor microenvironment. Non-lesion sites were also characterized by two hub species, Prevotella melaninogenica and Segatella oulorum.

CONCLUSION: Our findings define a lesion-specific microbial signature of OSCC characterized by the depletion of health-associated taxa, enrichment of pro-inflammatory pathobionts, and predicted associations with metabolic pathways implicated in carcinogenesis. These alterations reflect a predicted functionally altered tumor microenvironment.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Huang TY, Chen LL, Peng FS, et al (2026)

Effects of two different perineal preparations before vaginal birth on maternal and neonatal infections and hospital resources: A randomized controlled trial.

European journal of midwifery, 10:.

INTRODUCTION: Perineal preparation during the second stage of labor may influence maternal and neonatal infection risk and healthcare resource utilization. Although povidone-iodine sterilization is traditionally used, microbial flora theory suggests that water cleansing may preserve normal flora without increasing infection while reducing workload and cost. This study compared water cleansing with povidone-iodine sterilization for perineal preparation at Far East Memorial Hospital, Taiwan, from 26 November 2024 to 5 June 2025.

METHODS: A randomized controlled trial design was employed, including 143 mothers randomly assigned to either the water cleansing group (n=72) or the povidone-iodine sterilization group (n=71). Outcome measures included maternal and neonatal infection parameters (maternal postpartum temperature, C-reactive protein, REEDA scores, neonatal temperature, and neonatal oral flora colonization), along with cleansing time and medical costs. Data were analyzed using t-tests, chi-squared tests, and generalized estimating equation (GEE).

RESULTS: GEE analysis revealed no significant differences between the two groups in maternal and neonatal infection indicators (REEDA, 95% CI: -0.53-0.18, p=0.337; maternal temperature, 95% CI: -0.06-0.21, p=0.278; neonate temperature, 95% CI: -0.12-0.19, p=0.636). The water group had significantly lower average medical costs than the povidone-iodine group (7.49 vs 110.92 TWD, t= -50.22, p<0.001), as well as a shorter cleansing time. Regarding neonatal flora colonization, the water group showed higher rates of normal flora (33.8% vs 15.5%) and lower rates of pathogenic bacteria (5.6% vs 12.7%, χ[2]=10.88, p=0.028).

CONCLUSIONS: Perineal preparation with water was not associated with an increased risk of maternal or neonatal infection or adverse neonatal oral microbial colonization at birth and was associated with lower medical costs. These findings suggest that water may be a safe and cost-effective alternative to povidone-iodine for perineal preparation among women with low-risk pregnancies in hospitals with high episiotomy rates. Further longitudinal studies are needed to determine the effects of intrapartum povidone-iodine exposure on neonatal microbiome development and its potential long-term health consequences.

CLINICAL TRIAL REGISTRATION: The study is registered on the official website of ClinicalTrials.gov.

IDENTIFIER: NCT06880445.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Abboud E, Rossi P, Crouzy B, et al (2026)

Characterization of the atmospheric microbiome in a semi-rural area of Central Europe using flow cytometry.

ISME communications, 6(1):ycag167.

Characterizing bioaerosols is important for understanding their potential impacts on the environment and public health. In this study, we developed a novel flow cytometry-based approach to determine the low nucleic acid (LNA), high nucleic acid (HNA), dead, and intact bioaerosol populations in samples collected with a wet cyclone at Payerne, Switzerland, during spring and summer 2024. We found that the average bioaerosol number concentration reached (2.47 ± 3.35)×10[4] m[-3]. The HNA and intact populations were the most abundant populations, representing the largest fraction of total bioaerosols within 65% and 97% of the samples, respectively. Our results show that the LNA can be composed of dead bioaerosols, which correlated strongly with atmospheric particulate mass. Quantitative Polymerase Chain Reaction (qPCR) and metagenomic analysis reveal significant correlations and associations (Spearman, PERMANOVA, and Mantel) between the different kingdoms analyzed, reflecting complex ecological interactions in the atmosphere among the communities. Despite this complexity, LNA was mainly associated with the archaea Nitrososphaerota and bacteria Actinomycetota, whereas HNA was enriched by fungal classes such as Pichiomycetes and Ustilaginomycetes. Pollen abundance was positively correlated with temperature and negatively correlated with relative humidity and pollution (NOx and NO2), as these conditions promote the formation of sub-pollen particles (pollen fragments) through osmotic (bursting) and oxidative stress. Factor analysis indicates a seasonal dynamics transition from plant-associated bioaerosols in the spring season, to other bioaerosol types to be co-emitted during summer. Overall, the integration of flow cytometry with molecular analysis provides a framework to characterize and quantify bioaerosols and provides new insights into the ecological structure, variability, and sources of the atmospheric microbiome.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Pan Q, Tsompanidou E, Hu W, et al (2026)

Faecalibacterium harmsenii sp. nov., an abundant but previously overlooked Faecalibacterium in the human gut.

ISME communications, 6(1):ycag221.

Faecalibacterium is one of the most abundant anaerobes in the human colon. At the genus level, this bacterium shows a strong positive association with human health. Expanding collections of isolates and metagenome-assembled genomes have revealed its species diversity, yet species-level functions remain so far underexplored. Here, we describe a novel species, Faecalibacterium harmsenii. In addition, we reclassify another isolate as a member of the recently reported Faecalibacterium langellae species. Despite close genomic relatedness, these isolates exhibit distinct physiological and biochemical traits, including differences in carbohydrate utilization, stress tolerance, enzymatic activity, Gram-staining and fatty acid composition. Our present comparative genomics analyses further uncover extensive functional diversity and plasticity across type strains, with F. harmsenii being distinguished by an expanded carbohydrate gene repertoire and reduced defense systems, mobile genetic elements and antibiotic resistance genes. Extending to the species, we identify species-specific ecological niches across hosts and differential sensitivities to human diseases, highlighting certain species as reliable biomarkers of gut health. Together, these findings refine our understanding of Faecalibacterium diversity and provide a framework for its use in microbiome-based diagnostics and therapeutic development.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Nett N, K Dumack (2026)

A Pan-European Whole-Microbiome Study of Wastewater Influent: Prokaryotes, Protists, Fungi, and Metazoa.

The Journal of eukaryotic microbiology, 73(5):e70112.

Microbial communities entering wastewater treatment plants (WWTPs) through untreated sewage represent an important interface between human, environmental, and treatment-associated microbiomes, yet our understanding of their biogeography remains poorly resolved, particularly for microbial eukaryotes. Using shotgun metagenomic time-series data from influent samples of seven WWTPs across a European latitudinal gradient, we analyzed the taxonomic composition and dynamics of bacteria, protists, fungi, and microscopic metazoa. Influent community composition varied with geographic location and season, with a pronounced north-south divergence driven by dominant taxa and stronger seasonal shifts observed at higher latitudes. Cross-domain associations were pervasive, suggesting that co-varying bacterial and eukaryotic components structure the incoming microbial pool. Our findings provide a pan-European baseline for whole-microbiome wastewater surveillance and highlight that influent communities differ regionally and seasonally. These patterns may be relevant for downstream treatment-stage microbiomes, but direct effects on reactor community assembly and treatment performance require targeted sampling across treatment stages.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Zhao L, Long Y, Zeng K, et al (2026)

Chronic CeA[CRH] Activation Disrupts Colonic IL-22/Reg3g Signaling and Induces Depression-Associated Microbiome Shifts in Male Mice.

Journal of integrative neuroscience, 25(8):48170.

BACKGROUND: Psychological stress shapes brain-body interactions through bidirectionally signaling between central neural circuits and peripheral systems. Central amygdala corticotropin-releasing hormone (CeA[CRH]) neurons are key regulators of stress response and immune function. However, their chronic impact on the brain-gut-immune axis and gut microbiota remains poorly understood.

METHODS: We established a chronic stress model in mice by 14-day chemogenetic activating CRH neurons in the CeA. Behavioral assays were conducted to evaluate anxiety and depressive-like phenotypes. mRNA expression level of cytokines, tight junction proteins and antimicrobial peptide were compared in spleen or colon using qPCR between CeA[CRH] activated group and control. In addition, 16S rRNA sequencing was performed to characterize changes in the microbial composition.

RESULTS: Chronic activation of CeA[CRH] neurons showed a tendency toward anxiety-like behavior and significantly disrupts splenic and colonic immune homeostasis. Notably, the colonic interleukin-22 (IL-22)/regenerating islet‑derived protein 3 gamma (Reg3g) mucosal defense axis was suppressed. Microbiota analysis revealed a shift toward a depression-associated profile, characterized by an increase in potentially pathogenic taxa (e.g., Eggerthella and Actinomycetota) and a reduction in short-chain fatty acid producers (e.g., Ruminococcaceae and Roseburia). These microbial alterations are consistent with clinical observations in patients with depression, supporting the translational relevance of mental disorders and gut microbiota.

CONCLUSIONS: Chronic activation of CeA[CRH] neurons drives coordinated immune, gut barrier, and microbiota alterations, including Claudin-2 upregulation and suppression of the IL-22/Reg3g axis, with IL-22 significantly reduced and Reg3g showing only a decreasing trend. These findings suggest a neuro-immune-microbiota pathway linking central stress circuits to peripheral dysfunction. Targeting IL-22 signaling, epithelial barrier integrity, or microbiota composition may represent promising therapeutic strategies for chronic stress-related disorders.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Zhang T, Niu J, Hu X, et al (2026)

Akkermansia muciniphila and Its Bioactive Derivatives: Emerging Regulators of Healthy Aging.

Aging cell, 25(9):e70702.

The global aging trend underscores the urgent need for innovative interventions against aging-related decline. Accumulating evidence identifies Akkermansia muciniphila (A. muciniphila) as a key gut microbiota regulator of aging, with its depletion associated with age-related diseases (ARDs), whereas its abundance is enriched in healthy centenarians. This review summarized current evidence linking A. muciniphila to aging, examining their causal relationship, the roles of its bioactive derivatives, underlying mechanisms in aging and ARDs, findings from human clinical trials, and challenges in therapeutic translation. Clinically, A. muciniphila depletion correlated with aging and various ARDs, while its supplementation effectively ameliorated neurodegenerative disorders, metabolic dysfunction, musculoskeletal decline, intestinal barrier dysfunction, and atherosclerosis. Mechanistically, A. muciniphila and its derivatives (Amuc_1100, Amuc_1409, extracellular vesicles, and metabolites such as SCFAs) exerted anti-aging effects by enhancing intestinal barrier function, maintaining metabolic homeostasis, suppressing chronic inflammation, and modulating immune function, ultimately improving glucolipid metabolism, insulin sensitivity, cognitive function, musculoskeletal health, and vascular health. Emerging clinical trials further demonstrated its translational potential in ameliorating age-related sarcopenia, metabolic dysfunction, and respiratory symptoms. Despite promising preclinical and clinical results, translational applications reserve challenges related to strain heterogeneity, antimicrobial resistance gene transfer risk, biosafety, production stability, and limited clinical validation in elderly populations. Future research should prioritize large-scale clinical trials to establish optimal dosage, safety, and long-term efficacy, while exploring combined microbiota-targeted therapies. Harnessing the diverse benefits of A. muciniphila may enable novel strategies for promoting healthy aging.

RevDate: 2026-09-04

Carella A, Carroll KC, E Munson (2026)

Update on novel, validly published, and included bacterial taxa derived from human clinical specimens and taxonomic revisions published in 2025.

Journal of clinical microbiology [Epub ahead of print].

This review summarizes novel taxon designations ascribed to prokaryotes derived from human primary clinical material during calendar year 2025, as well as proposed revisions to existing taxonomy. Major activity took place in the Streptococcus genus, as more than one dozen novel species were validly and effectively published, with two of these later classified as synonyms of Streptococcus thalassemiae. Moreover, whole genome sequencing and phylogenetic investigation of Streptococcus mitis group organisms resulted in a proposal to designate five species-level Streptococcus spp. taxa as Streptococcus mitis and an additional taxon as Streptococcus oralis subsp. dentisani. More than one dozen taxa were newly included in order Enterobacterales in 2025. Select novel taxa within genera Providencia and Enterobacter commonly possessed genotypes that conferred resistance to carbapenem and/or higher-generation cephem agents. Stenotrophomonas muris sp. nov. and Terrisporobacter muris sp. nov., initially characterized in gnotobiotic murine systems within the past 4 years, had clinical significance in human infection that was demonstrated in primary literature. The vast majority of the more than 70 novel obligate anaerobic taxa were derived from microbiome studies and had little ascribed clinical significance. Four novel obligate anaerobic Gram-negative taxa were shown to be of greater abundance in persons with Parkinson's disease than in those without. Updates to taxa previously published in the Journal of Clinical Microbiology compendia reveal that several could serve as reservoirs for multiple antimicrobial resistance determinants. One example is the non-glucose fermentative Gram-negative bacillus Pseudomonas juntendi.

RevDate: 2026-09-04

Claiborne C, Z Lyu (2026)

Meta-CD: a metagenomic sequencing coverage and depth calculator for target species.

Microbiology resource announcements [Epub ahead of print].

Metagenomic Coverage and Depth Calculator (Meta-CD) is a convenient, biologist-friendly tool for determining coverage and depth to enhance taxonomic detection, functional profiling, and metagenome-assembled genome (MAG) recovery in metagenomics. It supports experimental design and post-sequencing analysis, modeling how genome size, relative abundance, sequencing depth, and DNA quantity influence detection of target species.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Tamanna I, Salonen K, Mannochio-Russo H, et al (2026)

Emerging Microbial Lipid Shifts in a Multistage Simulated Gut Inoculated with Human Fecal Microbiota.

Journal of proteome research, 25(9):4577-4588.

Food residues that bypass human digestion are further digested by gut microbes, leading to the production of diverse metabolites, including lipids. To investigate how lipids in our intestine are affected during this transition, we used a colon simulator with four distinct vessels (V1-V4) that mimic the proximal to distal part of the human colon. In total, 44 samples were collected from the colon simulator vessels (V1-V4). We observed dynamic shifts in a diverse array of microbially linked lipid molecules in the simulated intestinal chyme, including bile acids and N-acyl amides with short- and odd-chain lipids. Histamine-linked N-acyl lipids (histamine-C5) increased from the proximal to the distal colon vessels (pH 5.5-7.0), whereas putrescine-linked ones (putrescine-C19:2), initially abundant in the media, decreased across the colon vessels. We uncovered dynamic associations between in vitro-derived short-chain N-acyl lipids (C4:0, C5, C6, and C7 conjugates) and major lipid species such as cholesterol esters, phosphatidylethanolamines, ceramides, and sphingomyelins. To determine the broader relevance of these findings, we applied a reverse metabolomics approach and examined N-acyl lipid profiles in human small intestine and fecal samples from public data sets. Our results validate the colon simulator as a dynamic model for studying microbially transformed metabolites and suggest its potential utility as a platform for discovering novel microbial metabolites with relevance to human and animal health.

RevDate: 2026-09-04

de Kreek F, Hertzberger R, van Eeden F, et al (2026)

Intra-individual genetic diversity of vaginal Lactobacillus crispatus revealed through citizen science-driven isolation and pangenome analysis.

Journal of applied microbiology pii:8785784 [Epub ahead of print].

AIMS: A vaginal microbiome dominated by Lactobacillus crispatus is associated with positive reproductive and sexual health outcomes, yet intra-individual genetic diversity within this species remains largely unexplored. This study characterised inter- and intra-individual genomic variation in L. crispatus strains isolated through a citizen science initiative and assessed implications for multi-strain probiotic development.

METHODS AND RESULTS: Fifty-three women participated in this citizen science project. Self-sampling resulted in 48 shotgun metagenomes. Twenty-two participants isolated their own L. crispatus strains using selective enrichment and LAMP-based species confirmation, resulting in 53 whole-genome-sequenced isolates. L. crispatus dominated 20 of 48 metagenomes (50.1-99.6% relative abundance). Pangenome analysis revealed 3 456 gene families, of which 43.7% were core and 56.3% accessory. A 14-kb plasmid harbouring a Fic-domain toxin-antitoxin protein, but devoid of antimicrobial resistance genes, was present in 44 of 53 strains. Strains from the same individual clustered closely together yet harboured 1-123 gene differences. Intra-individual variation was observed in the pullulanase type I gene required for glycogen degradation: 40 strains were predicted to grow on glycogen, six showed genetic disruptions with unknown consequences, and seven were predicted to lack this ability entirely. Variation within individuals was also found for bacteriocin classes and CRISPR-Cas genes.

CONCLUSIONS: Substantial functional diversity exists within L. crispatus, even among strains from the same individual, supporting the rationale for multi-strain vaginal probiotics. This citizen science approach enabled discovery of host-specific adaptations while ensuring participant ownership of their strains.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Yan J, S Ding (2026)

Integrative multi-omics analyses suggest a candidate microbial metabolite-associated host gene network in ulcerative colitis.

Immunologic research, 74(1):.

Ulcerative colitis (UC) is associated with gut microbial dysbiosis, but the host molecular alterations potentially linked to microbially derived metabolites remain incompletely understood. We integrated Mendelian randomization (MR), microbial metabolite annotation, computational target prediction, colonic transcriptomics, network analysis, and machine learning. MiBioGen microbiome GWAS data were used as exposures and FinnGen Release 12 ULCERENTER as the outcome. Metabolites linked to MR-prioritized taxa were retrieved from GutMGene, and human targets were predicted using SwissTargetPrediction and SEA. UC-related genes were defined by integrating differential expression analysis and WGCNA and then intersected with predicted metabolite targets. MR prioritized one family and eight genera showing nominal genetically supported associations with UC, but none remained significant after Benjamini-Hochberg FDR correction. Three prioritized genera were linked to 15 microbe-metabolite records, corresponding to 13 unique metabolites; nine were retained for target prediction, yielding 277 unique predicted human targets. Transcriptomic analysis identified 1,530 DEGs and a 312-gene MEgrey60 module, with 273 overlapping genes, producing 1,569 unique UC-related genes. Their intersection with the 277 predicted targets yielded 47 candidate genes. Enrichment analyses highlighted mainly metabolic and lipid-related processes. Random Forest showed the highest mean AUC across the two independent external benchmarking cohorts, and SHAP prioritized EPHX1, HSD17B2, IGFBP5, and MMP10. IBDome analysis showed inflammation-associated expression differences in these genes. This study provides a genomics-informed, hypothesis-generating framework that prioritizes candidate microbe-metabolite-host relationships in UC for future experimental validation.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Zhou Y, Del Toro S, MY Zeng (2026)

Nutritional regulation of gut-brain immune crosstalk across the lifespan.

Gut microbes, 18(1):2725371.

The gut-brain immune axis integrates microbial, immune, and neural signals to regulate neurodevelopment, homeostasis, and disease susceptibility. Early-life nutrition, particularly human milk oligosaccharides, shapes beneficial microbiota composition, enhances hippocampal plasticity, promotes anti-inflammatory microglia polarization, and fosters immune tolerance. Gut microbiota-derived metabolites, including short-chain fatty acids, tryptophan derivatives and secondary bile acids, regulate microglia maturation, astrocyte function, T cell differentiation, neurotransmitter production, and vagus nerve signaling. These processes influence synaptic pruning, neurogenesis, and neuroinflammation. Adaptive immune cells in the central nervous system, notably meningeal and infiltrating CD4 T cells, further connect peripheral immunity to neuronal responses through cytokines, such as IL-4, IFNγ, and IL-17A. Nutritional imbalances may exacerbate disease-associated microglia and pathogenic T cell activity in Multiple Sclerosis, Alzheimer's disease, and autism spectrum disorders. In aging, diet helps mitigate "inflammaging" by countering metabolic shifts in microglia and lymphocytes. This review examines how nutrition modulates bidirectional gut-brain immune crosstalk across the lifespan.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Alperstein L, Nappi J, S Egan (2026)

Mariculture Probiotics: A Scoping Review of Research Trends, Knowledge Gaps and Opportunities.

Marine biotechnology (New York, N.Y.), 28(5):.

The use of probiotics - live microorganisms - to enhance growth and prevent disease in mariculture species is an emerging alternative to conventional methods including antibiotics, vaccines and chemical intervention. While others have reviewed specific host organisms and probiotic genera, this review synthesises the scientific literature on the use of probiotics across a range of marine organisms to identify knowledge gaps and research opportunities. We identified widespread methodological heterogeneity, making direct inter-study comparisons difficult. Despite this limitation, 86% of in vivo studies documented positive outcomes following probiotic administration. Crustacean and finfish research dominates the field, encompassing 77% of the current literature, while molluscs, macroalgae and other invertebrates remain relatively understudied despite their significant ecosystem services and contribution to aquaculture. Probiotics provide multiple reported benefits to marine hosts, including increased growth and survival, and protection against pathogens. Bacillus and Lactobacillus from terrestrial environments are the dominant probiotics used across all studies, while marine-derived probiotic genera including Pseudoalteromonas, Vibrio, Phaeobacter, Shewanella, and Halomonas showed benefits across several hosts but remain relatively underutilised. Approximately 34% of publications evaluated the use of microorganisms isolated from the same host species in which the probiotics were tested. This review highlights the opportunity for further research into underutilised autochthonous probiotic genera and development of standardised research guidelines. We propose that future research should prioritise understanding probiotic mechanisms of action, and their use in rapidly expanding and understudied systems including macroalgae and molluscs, to ensure continued productivity with minimal impact on marine ecosystems.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Souza N, Andaló V, Indjai LR, et al (2026)

Spatial distribution of entomopathogenic nematodes and their relationship with soil chemical attributes in tropical agroecosystems.

Environmental monitoring and assessment, 198(9):.

The distribution of entomopathogenic nematodes (EPNs) in agricultural soils is influenced by complex interactions between edaphic factors and crop management practices, yet these relationships remain poorly understood under tropical conditions. This study evaluated the spatial distribution of EPNs and their association with soil chemical attributes in five crop systems in southeastern Brazil. A total of 82 soil samples were collected and analyzed using insect-baiting techniques and geospatial tools, including kernel density and interpolation methods. EPN occurrence varied across crops and was positively associated with higher concentrations of potassium and iron, while an inverse pattern was observed for copper. These results suggest that micronutrients may indirectly influence EPN distribution by modulating soil microbial communities and plant-soil interactions. Although causal relationships cannot be definitively established, the spatial patterns identified highlight the importance of soil chemical composition in structuring beneficial soil fauna. The integration of geospatial analysis provides a valuable framework for optimizing the application of biological control agents in Integrated Pest Management (IPM) programs. These findings contribute to a better understanding of soil ecological dynamics and support the development of more sustainable agricultural practices.

RevDate: 2026-09-04

Román R, Maestre FT, E Couradeau (2026)

Rainfall-induced microbial resuscitation reveals functional decoupling across biocrust succession.

The ISME journal pii:8785853 [Epub ahead of print].

Dryland ecosystems rely on infrequent rainfall pulses to activate soil microbial communities, yet the fraction and identity of microbes resuscitating after hydration remain unclear. We applied bioorthogonal non-canonical amino acid tagging coupled with fluorescence-activated cell sorting (BONCAT-FACS) and 16S rRNA gene sequencing to identify translationally active bacteria in early (L-BSC) and late (D-BSC) successional cyanobacteria-dominated biocrusts subjected to 3 mm simulated rainfall under light and dark conditions. Our results reveal that only a small subset of the microbial community resumes activity within six hours, with higher active cell abundances in mature crusts. Microbial activity patterns were largely independent of light exposure and showed partial decoupling from total community composition, indicating that presence does not predict short-term function. These findings suggest that biocrust maturity shapes microbial activation dynamics and that functional responses to precipitation pulses are governed by a conserved pool of fast responders, informing predictions of dryland soil microbiome resilience under changing precipitation regimes.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Sempert T, Budzinski L, Kempkens R, et al (2026)

A Step-by-Step Guide to Successful Multiparametric Microbiota Flow Cytometry.

Current protocols, 6(9):e70460.

The role of the human microbiota in host health is an important area of research. Conventional characterization of the complex microbial communities colonizing the human body is primarily performed using culture-based or high-throughput sequencing approaches, which have improved general understanding yet lack cellular features relevant for interaction and function at the single-cell level. Flow cytometry is an established tool for single-cell analysis, and recent improvements, such as increased resolution of small cells and particles, offer possibilities for characterizing complex microbial communities. Here, we describe an updated protocol to characterize complex microbial communities derived from human stool samples at the single-cell level by multiparametric microbiota flow cytometry. Our protocol covers the process from the isolation of bacteria from stool, preparation of cryo-stocks, staining procedure for phenotypic features of the bacteria, and flow cytometric analysis. Our phenotypic characterization includes light scattering properties, quantitative DNA staining, isotype-specific staining of host-antibody coating, and profiling of bacterial cell surface sugar moieties. In addition, we highlight the importance of determining the bacterial load for improved biological interpretation. External staining controls ensure reproducibility and quality controls. Additionally, we suggest a downstream analysis pipeline involving segmentation of multivariate data by a self-organized map (SOM) and machine learning to generate specific microbiota fingerprints. Optionally, bacteria with specific phenotypic characteristics can be isolated by fluorescence-activated cell sorting (FACS) for further investigation. Our protocol can be applied to any microbial community or sample source and offers the flexibility to be expanded with additional phenotypic markers. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Preparation of cryo-preserved bacterial stocks from a single-cell microbiota suspension derived from native human stool sample Basic Protocol 2: Staining protocol for cryo-preserved microbiota stocks and acquisition using a flow cytometer.

RevDate: 2026-09-04
CmpDate: 2026-09-04

Li T, Zhang S, Wang Z, et al (2026)

Soil extracellular DNA fragments show variable degradation rates among sequences and environmental conditions.

eLife, 15: pii:110251.

While extracellular DNA (eDNA) persistence substantially influences soil microbiome investigations, its degradation kinetics remain poorly quantified. Here, we developed a primer-labeled DNA approach coupled with microcosm incubation to determine the overall and sequence-specific degradation rates of eDNA amplicon fragments across China. We observed substantial variations in the overall degradation rates of extracellular 16S rRNA gene amplicon fragments among the study sites, with degradation rate constants ranging from 0.05 to 0.16 day[-1]. The overall degradation rate constants showed significant correlations with soil moisture content, prokaryotic abundance, prokaryotic community profiles, and mean annual precipitation. The significant influences of moisture content on the overall degradation rates were further verified by a moisture gradient microcosm experiment. The sequence-specific degradation rate constant profiles were additionally correlated with pH, nitrogen content, and mean annual temperature. Furthermore, propidium monoazide-based exclusion of eDNA signals significantly altered soil prokaryotic abundance, richness, and prokaryotic community profiles, and the pool sizes of sequence-specific extracellular 16S rRNA gene amplicon fragments were significantly correlated with their respective degradation rates. This study developed a methodology for determining the overall and sequence-specific degradation rates of eDNA amplicon fragments, highlighting the profound influences of eDNA on soil microbial research and informing the optimization of environmental DNA technologies.

RevDate: 2026-09-04

Anonymous (2026)

Correction to: Pseudomonas aeruginosa adaptation and persistence in the aspergilloma microbiome revealed by integrated multi-omics.

RevDate: 2026-09-04

Kimura S, Nishi K, Kawamoto K, et al (2026)

Nasal irrigation increases upper-airway microbial diversity: a prospective pilot study.

Acta oto-laryngologica [Epub ahead of print].

BACKGROUND: Nasal irrigation is widely recommended for chronic rhinosinusitis and allergic rhinitis, but its effects on the upper-airway microbiome remain unclear.

OBJECTIVE: To determine whether 30 days of buffered isotonic saline nasal irrigation alters bacterial diversity in the nasal cavity, nasopharynx, and oral cavity.

MATERIAL AND METHODS: Ten volunteers performed twice-daily irrigation for 30 days. Swabs from the nasal cavity, nasopharynx, and posterior tongue were collected at baseline and day 30. Bacterial communities were analysed by 16S rRNA gene sequencing. The primary endpoint was change in nasal Shannon diversity; other microbiome, endoscopic, and correlation analyses were exploratory.

RESULTS: Nasal Shannon diversity increased significantly (median [IQR], 1.02 [0.80-1.48] vs 1.50 [1.37-1.66]; p = 0.040), whereas nasopharyngeal and oral diversity did not. Micrococcaceae, Lactobacillus, and Corynebacterium showed directional increases but did not survive FDR correction. Nasal mucosal erythema decreased (p = 0.039). No participant developed acute sinusitis or severe complications; transient mild discomfort occurred in three.

CONCLUSIONS AND SIGNIFICANCE: Thirty-day saline nasal irrigation was associated with increased nasal bacterial diversity and reduced mucosal erythema. These single-arm pilot findings are exploratory and warrant validation in larger controlled studies.

RevDate: 2026-09-04

Yin Y, Pommier T, Zhang X, et al (2026)

Competition between resident rhizosphere bacteria enhances phytopathogen suppression via emergent antagonism.

The ISME journal pii:8785901 [Epub ahead of print].

Resident bacterial interactions can shape the invasion resistance of rhizosphere microbiomes, but whether interactions between weakly antagonistic resident bacteria can generate emergent antagonism against invading pathogens remains poorly understood. Here, we used a systematic pairwise interaction screening to identify Ralstonia pickettii RAL5 and Acinetobacter oleivorans ACI4 bacterial pair, that together provided a strong suppression of the phytopathogenic R. solanacearum Rs1115 strain. Although RAL5 and ACI4 monocultures only weakly inhibited pathogen growth, the RAL5-ACI4 co-cultures strongly suppressed the Rs1115, which was associated with asymmetric competition where the RAL5 dominated the ACI4 species. In line with this competitive asymmetry, broad transcriptional reprogramming was detected in RAL5 and only limited stress- and catabolism-associated responses in ACI4. The increased suppressiveness of co-cultures was associated with clear shifts in the extracellular metabolite profile, including the accumulation of candidate antimicrobial metabolites (e.g., a novobiocin-like feature and 4-aminophenol), and with the release of intracellular contents from ACI4 following RAL5-mediated lysis. The observed emergent antagonism also held in greenhouse experiments with tomato, where the RAL5-ACI4 consortium reduced R. solanacearum abundance and bacterial wilt severity relatively much more compared to when either strain was applied alone. Together, these results suggest that competitive interactions between resident bacteria can activate latent biocontrol potential in rhizosphere microbiomes, providing a new approach to harness resident bacterial interactions for enhanced pathogen suppression and biocontrol.

RevDate: 2026-09-04

Cisneros-Martínez AM, Varela MÁF, González-Serrano F, et al (2026)

Exploring the ecological drivers of bacteriophage diversity and functional viral potential in the skin of the axolotl Ambystoma altamirani.

FEMS microbiology ecology pii:8785999 [Epub ahead of print].

Bacteriophages play important roles in shaping microbial community dynamics across diverse environments. In the amphibian skin, most microbiome studies have focused on bacteria and their interactions with the fungus Batrachochytrium dendrobatidis (Bd), leaving other microbial components, including viruses, largely unexplored. Here, we present the first characterization of the viral community in the amphibian skin microbiome, focusing on ecological drivers of bacteriophage diversity and functional potential in the axolotl Ambystoma altamirani. Using public shotgun metagenomes, we found that the viral fraction was dominated by bacteriophages of the class Caudoviricetes. Bacteriophage diversity was significantly associated with local physicochemical parameters at the time of sampling, and showed a strong positive correlation with bacterial diversity, whereas no significant associations were detected with the presence of Bd. In addition, seasonality influenced the composition and properties of bacteria-bacteriophage co-abundance networks. Functional annotation of assembled bacteriophage sequences revealed a diverse functional potential, including putative auxiliary metabolic genes, superinfection exclusion, toxin-antitoxin, and virulence factors. Overall, these findings highlight the ecological relevance of bacteriophages in amphibian skin microbiomes and underscore the need for further studies on their role in the amphibian host's health.

RevDate: 2026-09-04

Royle JWL, Applebaum I, Wasan JP, et al (2026)

Host-specific soil oomycete communities are spatially repeatable across natural grasslands.

Canadian journal of microbiology [Epub ahead of print].

Soil oomycetes contain some of the most devastating plant pathogens, and are widespread within the soil microbiome, yet how individual plant species structure oomycete communities in natural soils, and whether any such structuring is consistent across space, remains poorly resolved. Because host-specific pathogen accumulation is a central prediction of plant-soil feedback theory but is rarely tested outside greenhouse conditions, we focused on whether the host-specific fraction of these communities is preferentially pathogenic. Using oomycete-specific ITS amplicons, we sequenced rhizosphere-associated and paired bulk soils from four grassland species across 25 sites on the Canadian Prairies spanning more than 200,000 km[2], totalling 1800 samples. Each host supported a distinctive core of taxa, with two species more likely to host pathogenic taxa unique to their rhizosphere. This enrichment was decoupled from richness of oomycete taxa in the rhizosphere, indicating selective accumulation rather than a by-product of resource-rich environments. Community composition also differed among hosts after accounting for site level edaphic variation. Host plant identity therefore leaves a detectable, spatially repeatable imprint on soil oomycete communities, one expressed most strongly through the selective accumulation of pathogenic taxa.

RevDate: 2026-09-04

Kan Y, Fu Y, Yang W, et al (2026)

Rhizosphere microbiome assembly and functional enrichment drive salt tolerance in wheat.

Journal of environmental management, 417:130869 pii:S0301-4797(26)02329-7 [Epub ahead of print].

Soil salinization is a major constraint on wheat production, as seedling-stage stress strongly constrains early growth and potential yield. However, the mechanisms by which the rhizosphere microbiome mediates varietal differences in salt tolerance remain poorly understood. Here, we compared a salt-tolerant wheat cultivar (Jimai60, JM60) and a salt-sensitive cultivar (Guomai301, GM301) grown in saline-alkali soil. Integrating soil physicochemical, enzymatic analyses and 16S rRNA gene and shotgun metagenomic sequencing, we investigated rhizosphere microbiome assembly, network structure, and functional potential at the seedling stage. JM60 assembled a distinct rhizosphere microbiome enriched in Bacteroidota, with Sphingobacterium acting as a keystone taxon in a more stable co-occurrence network. In contrast, GM301 was dominated by Zobellella and exhibited increased negative microbial interactions, indicating a reduced network that is structurally more cooperative. Metagenomic analyses showed enrichment in JM60-associated microbiomes of genes linked to oxidative stress resistance (katE), central carbon metabolism (pdhD), and nitrogen utilization (hutF), suggesting enhanced redox homeostasis, nutrient cycling, and ion balance regulation. These functional traits aligned with higher leaf antioxidant enzyme activity and altered rhizosphere nutrient profiles in JM60. Our findings demonstrate that wheat salt tolerance is linked to assembly of a functionally enriched rhizosphere microbiome, highlighting microbiome-driven mechanisms for improving crop resilience in saline soils.

RevDate: 2026-09-04

Bhowmik M, Jaiswal S, S Haldar (2026)

Metabolic fingerprint establishes ecological linkage between polychaete gut microbes with surrounding benthic ecosystem.

Marine environmental research, 222:108388 pii:S0141-1136(26)00557-X [Epub ahead of print].

In gut-associated symbiosis, microbes play a pivotal role in shaping the habitat and diet preferences of the host. In intertidal deposit-feeding polychaetes, gut microbial assemblages are influenced by both water and sediment biota. In the present study, the metabolic profiling of gut microbial communities of Perinereis sp. was compared with its surrounding environmental microbiome. Effective utilization of amine, amino acids, and carbohydrate substrates by gut microbes was noticed within 48 h of incubation. Moreover, it reached an average well colour development of 0.54 at 120[th] hour of incubation. Low Gini coefficient (0.332) revealed a substrate-generalized communities with diverse metabolism pathways persist in the gut. The multi-level pattern analysis indicated some important substrates that were commonly utilized by gut as well as sediment microbes. Similarity percentage revealed maximum resemblance (64.1%) of gut microbes with its sediment which possibly explained by their deposit-feeding trait and diet preferences. Further, a generalized additive model was applied to study the non-linear trend in time-dependent utilization of carbon guilds by different microbial communities. The results overall indicate the functional overlaps in utilization pattern and possibly explain how polychaete gut microbiome share functional similarity with environmental microbiome with maintaining a distinct community structure. The capacity of utilizing wide varieties of substrate denote high metabolic plasticity of gut microbes which may help in host's survival in the organically enriched mudflat. Furthermore, overlaps in substrate utilization reveal that common environmental factors drive the ecological similarity between gut and sediment microbes.

RevDate: 2026-09-04

Mollica L, Tassi E, Copaloni A, et al (2026)

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Clinical lung cancer, 27(8):14-21 pii:S1525-7304(26)00109-9 [Epub ahead of print].

BACKGROUND: Immune checkpoint inhibitor (ICI) monotherapy is the standard first-line treatment for advanced non-small cell lung cancer (NSCLC) with PD-L1 ≥ 50%; however, up to 30% of patients experience early progression or death, including cases of hyperprogressive disease (HPD). High baseline levels (≥ 30.5%) of circulating CD10[-] low-density neutrophils (LDNs) have been associated with increased HPD occurrence. Emerging evidence suggests that combining ICI with platinum-based chemotherapy (PCT) may mitigate the risk of HPD. Currently, no prospective studies have addressed HPD prevention in this context.

PATIENTS AND METHODS: HYPERBOLIC (NCT07274384) is a phase 2, randomized, open-label, multicenter, international trial evaluating whether adding 3 cycles of PCT to first-line cemiplimab reduces HPD rate in stage IV NSCLC with PD-L1 ≥ 50% and CD10[-] LDNs (identified by flow cytometry as CD15⁺CD11b⁺ within the PBMC fraction, with immature cells defined by loss of CD10) ≥ 30.5%. Seventy-four patients will be randomized (1:1 ratio) to receive cemiplimab alone or cemiplimab plus 3 PCT cycles, followed by cemiplimab maintenance. Randomization will be stratified by Lung Immune Prognostic Index. The first computed tomography scan at week 7 after treatment start will assess HPD occurrence, defined as RECIST v 1.1. disease progression with a delta tumor growth rate (ΔTGR) ≥ 50% and/or TGR ratio ≥ 2. The primary endpoint will be the combined rate of HPD and early death (death within 12 weeks with no radiological evaluation). Secondary endpoints will be HPD rate according to alternative definitions, overall survival, progression free survival, objective response rate, and safety. An extensive translational research platform will include spatial transcriptomics of tumor tissue, single-cell RNA sequencing of PBMCs, circulating-free DNA and plasma factors profiling, and saliva/stool microbiome genomics and metabolomics, to longitudinally explore tumor-host dynamic interactions during treatment.

CONCLUSION: to our knowledge, HYPERBOLIC is the first prospective, biomarker-driven trial investigating early treatment escalation based on HPD risk in PD-L1-high NSCLC.

RevDate: 2026-09-04

Frangieh MR, Saad M, Fattouh N, et al (2026)

Antibiotics and nanoparticles in Parkinson's disease: From gut microbiota dysbiosis to neuroprotection and targeted nanotherapies.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 203:119903 pii:S0753-3322(26)00939-X [Epub ahead of print].

Parkinson's disease (PD) is increasingly linked to gut-brain axis dysfunction. While broad-spectrum antibiotics may contribute to gut dysbiosis, which has been associated with an increased abundance of curli-producing Enterobacteriaceae and processes implicated in α-synuclein aggregation, certain antibiotic classes, particularly tetracyclines and β-lactams, have demonstrated neuroprotective properties in pre-clinical models of PD. This creates a therapeutic paradox: antibiotics may exert either beneficial or detrimental effects depending on many factors including host microbiome composition. Importantly, much of the current evidence remains observational or pre-clinical, and a direct causal relationship between antibiotic exposure and PD has not yet been established. This review synthesizes current epidemiological, mechanistic, and pre-clinical evidence regarding this paradox and explores the emerging role of nanotechnology in resolving it. Preclinical studies suggest that nanoparticle-based drug delivery systems may enhance BBB penetration and enable more targeted drug release. Such approaches have been proposed as a means to reduce systemic exposure and potentially limit microbiota disruption, although these benefits have not yet been demonstrated in clinical PD populations. We further discuss the translational hurdles, including nanotoxicity and regulatory requirements, and propose a roadmap for future research that integrates metagenomics with precision nanomedicine. Collectively, these findings provide a framework for future investigation of targeted therapeutic strategies for PD. However, substantial mechanistic, clinical, and translational validation is required before their therapeutic potential can be established.

RevDate: 2026-09-02

Petry B, Boggiatto PM, Buckley A, et al (2026)

Temporal transcriptomic and microbiome changes in American bison during experimental SARS-CoV-2 challenge.

G3 (Bethesda, Md.) pii:8780185 [Epub ahead of print].

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to pose a threat to humans as well as domestic and wild animals. The variability in severity of clinical signs, the zoonotic potential, and the host-specific response to infection contribute to the persistence of circulation of disease. In wildlife species, white-tailed deer have been shown to be more permissive to infection than bovids. However, among bovids, American bison have shown a greater susceptibility than cattle. In this study, we investigate the transcriptomic response to experimental SARS-CoV-2 infection in bison over time. Substantial numbers of differentially expressed genes were identified between pre- and 2, 5, 7, 14, and 21 days post-inoculation. Kyoto Encyclopedia of Genes and Genomes and Gene Ontology term analysis identified associations with immune response, inflammatory response, and viral infection including COVID-19. Ingenuity Pathway Analysis of the coronavirus pathway highlighted differences in signaling at days 2 versus 21 post-inoculation. We additionally examined changes in the nasal microbiome of bison over the course of experimental infection, which suggested an increase in opportunity for secondary infection causing pathogens such as Mannheimia. Collectively, this study presents a profile of bison transcriptomic response to SARS-CoV-2 infection and continues to expand our understanding of variation in host response.

RevDate: 2026-09-02

Abedi AA, Pourbozorg G, Abdou M, et al (2026)

Changes in the Management of Periprosthetic Joint Infection Over the Past 50 Years.

The Journal of bone and joint surgery. American volume pii:00004623-990000000-01965 [Epub ahead of print].

➢ Periprosthetic joint infection (PJI) remains a major complication of joint arthroplasty, associated with morbidity and health-care burden. Although room for progress remains, the management of PJI has evolved over the past 50 years from empiric, procedure-centered approaches to structured, evidence-based, and biologically informed strategies.➢ This article summarizes key developments in the prevention, diagnosis, and treatment of PJI, driven by advances across multiple clinical and scientific subspecialties.➢ Diagnostic approaches have advanced from reliance on clinical findings and culture to a multimodal framework integrating validated criteria, serological and synovial biomarkers, and molecular techniques. Surgical management has similarly evolved toward individualized strategies, including debridement with implant retention, 1-stage or 2-stage revision, and salvage surgery tailored to host, pathogen, and disease characteristics.➢ Advances in microbiology, particularly the recognition of biofilm and the emerging role of the human microbiome, have further reshaped the understanding of PJI. Overall, this article examines how developments in prevention, diagnosis, surgical treatment, and microbiology have driven a transition toward precision-based, biology-informed, and individualized management of PJI.

RevDate: 2026-09-02
CmpDate: 2026-09-02

Feng C, Gao G, He Q, et al (2026)

Bifidobacterium animalis subsp. lactis V9 overcomes CYFRA 21-1-linked immunochemotherapy resistance in NSCLC via microbial metabolites.

Science advances, 12(36):eaeg8202.

Gut dysbiosis drives therapeutic resistance, yet the relationships among typical tumor markers, gut microbiota, and treatment efficacy remain poorly defined. Here, elevated serum CYFRA 21-1 in advanced non-small cell lung cancer (NSCLC) correlates with gut dysbiosis, including Bifidobacterium animalis depletion and reduced immunomodulatory metabolites. Fecal supernatant from patients with high-CYFRA attenuated immunochemotherapy efficacy in tumor-bearing mice, linked to disrupted tryptophan and phenylalanine metabolism. Adjuvant B. animalis subsp. lactis V9 enhanced tumor control and antitumor immunity, coinciding with elevated quinaldic acid and catechol, metabolites associated with caspase-dependent apoptosis and ferroptosis. Cell-free fecal supernatant transferred antitumor effects, independent of bacterial colonization. In a randomized, double-blind, placebo-controlled pilot trial (n = 30), adjunctive B. lactis V9 associated with a higher objective response rate (47% versus 33%), disease control rate (87% versus 67%), and prolonged progression-free survival in responders, who exhibited enriched B. animalis and elevated quinaldic acid/catechol (area under the curve = 0.73/0.82). These findings suggest CYFRA 21-1 may identify a modifiable, microbiome-linked state of treatment resistance.

RevDate: 2026-09-02

Lei S, Qiu X, Wang Z, et al (2026)

Gut microbial H2S promotes metabolic dysfunction in mice via hepatic PPARα suppression.

The ISME journal pii:8780319 [Epub ahead of print].

This study investigates the role of gut microbiota-derived hydrogen sulfide (H2S) in obesity and glucose metabolism disorders. By integrating human gut metagenomic data, intervention experiments in mouse models, and in vitro cellular assays, we identified a signature of microbial sulfur metabolism in human cohorts and provided experimental evidence for its causal role and underlying metabolic mechanisms in mice. In clinical cohorts with obesity and glucose metabolism disorders, we observed a notable enrichment of genes involved in sulfur transport and H2S production. In mouse models, administration of H2S-producing Desulfovibrio desulfuricans, engineered Escherichia coli expressing phsABC, and the H2S donor NaHS consistently induced body weight gain and impaired glucose tolerance. Transcriptome analysis and cellular experiments indicated that H2S was associated with downregulation of the PPAR signaling pathway and lipid metabolism pathways in the liver, which may contribute to the abnormal accumulation of lipids and glycogen. Furthermore, rescue experiments using a PPAR agonist and an H2S adsorbent partially reversed these metabolic abnormalities. Collectively, our work provides experimental evidence in mouse models demonstrating that gut microbial H2S promotes metabolic dysfunction through hepatic PPARα suppression, providing potential targets for microbiome-based therapeutic interventions.

RevDate: 2026-09-02
CmpDate: 2026-09-02

Ren J, Yang Z, Liu W, et al (2026)

AResKGLM: a graph-grounded language-model framework for interpretable multi-hop antimicrobial resistance reasoning.

Briefings in bioinformatics, 27(5):.

Antimicrobial resistance (AMR) threatens microbiology and microbiome bioinformatics because resistance phenotypes are shaped by interactions among genes, mobile genetic elements, and functional environments across microbial communities. Prioritizing resistance determinants requires models that reason across knowledge graphs (KGs) linking genes, proteins, pathways, drugs, and microbial phenotypes. Existing graph-based methods compress this evidence into scalar scores, whereas large language models can produce explanations not grounded in structured evidence. We developed AResKGLM (Antimicrobial Resistance Knowledge Graph Language Model), a graph-grounded language-model framework for interpretable microbial AMR bioinformatics that serializes breadth-first-search-retrieved multi-hop paths and per-entity biomedical descriptions into a structured Context-Path-Question prompt. Llama-3-8B and DeepSeek-R1-7B are adapted with QLoRA to produce binary link predictions and concise reasoning traces. On the KIDs benchmark, AResKGLM (Llama-3-8B) achieved F1 = 0.8482, outperforming KG-BERT (0.7213), NBFNet (0.5260), and ULTRA (0.2541) (paired Wilcoxon $p = 1.2 \times 10^{-7}$). Its advantage increased with reasoning depth: F1 decreased from 0.9197 at 2 hops to 0.8148 at 6 hops, whereas KG-BERT dropped from 0.8110 to 0.6716. Counterfactual path corruption produced an apparent F1 of 0.000, mechanically forced by the probe label assignment; the operative diagnostic is the per-sample flip rate (0.04-0.16), consistent with sensitivity to supplied biological evidence rather than reliance on pretrained priors alone. Cross-species evaluation yielded F1 = 0.81-0.88 with Matthews correlation coefficient (MCC) = 0.35-0.54 on Mycobacterium tuberculosis, Pseudomonas aeruginosa, and Staphylococcus aureus. Temporal ranking of 81 post-2022 gene-drug associations achieved Precision@20 = 100% and AUC-PR = 0.855. AResKGLM offers an interpretable, reproducible framework for multi-hop AMR reasoning, linking candidate prioritization with mechanism-oriented hypothesis generation.

RevDate: 2026-09-02
CmpDate: 2026-09-02

Colajanni A, Uricaru R, Darko S, et al (2026)

Benchmarking methods for extracting microbial signal from host-dominated metatranscriptomes.

Briefings in bioinformatics, 27(5):.

Human RNA sequencing (RNA-seq) data originally generated for human transcriptome profiling are overwhelmingly dominated by host sequences, yet they often contain a small fraction of non-human reads that can be exploited for microbial detection. When such datasets are repurposed for secondary microbiome-oriented analyses, extracting and accurately classifying this weak microbial signal becomes technically challenging, and no ready-to-use pipeline currently exists. In this study, we evaluate computational strategies for filtering host reads and classifying microbial transcripts in host-dominated RNA sequencing data. We compare assembly-based approaches similar to those used in a previous study focusing on microbial translocation with state-of-the-art assembly-free methods, and assess their respective strengths and limitations using simulated datasets reflecting low microbial abundance. Our results show that assembly-based methods yield accurate taxonomic predictions but struggle at low read depth, whereas assembly-free methods are more robust in sparse settings at the cost of reduced precision. To leverage the complementarity of both approaches, we propose a hybrid pipeline that integrates assembly-based and assembly-free classification. On simulated data, this hybrid strategy improves microbial classification performance compared with either approach alone. Application to a real human metatranscriptomic dataset analyzed in a microbial translocation context illustrates the broader microbial signal captured by the hybrid approach, despite intrinsic challenges related to the absence of reliable ground truth and the risk of host read misclassification. Our work provides a framework for extracting microbial signals from host-dominated human metatranscriptomes, enabling the reuse of existing transcriptomic datasets for microbiome-related analyses, including but not limited to microbial translocation studies.

RevDate: 2026-09-02

Kim C, Kim C, Choi IG, et al (2026)

Contrasting effects of conventional PET and biodegradable PHB microplastics on population dynamics and gut microbiome responses in Daphnia magna.

Aquatic toxicology (Amsterdam, Netherlands), 300:107982 pii:S0166-445X(26)00279-1 [Epub ahead of print].

Research on the ecotoxicity of biodegradable microplastics (MPs) in Daphnia magna is rapidly growing, while their population-level effects remain unclear. This study compared the population-level effects of conventional MPs (polyethylene terephthalate, PET) and biodegradable MPs (polyhydroxybutyrate, PHB) on D. magna over 45 days. Gut microbiome and transcriptomic analyses were also conducted to elucidate the underlying mechanisms of the observed responses. PET MPs significantly (p < 0.05) decreased D. magna population biomass relative to control, whereas PHB MPs showed no significant effects. Both types of MPs altered the gut microbial community structure of D. magna, with PHB inducing a selective increase in potential degraders. Transcriptomic data showed that PET MPs significantly (p < 0.05) increased the expression of genes related to stress and defense responses. In contrast, PHB MPs significantly (p < 0.05) upregulated genes associated with metabolic processes. Further research incorporating direct assessment of PHB degradation, host energy assimilation, and wider range of exposure concentrations is required to clarify the mechanisms underlying the distinct responses to biodegradable and conventional MPs. This study highlights the importance of considering polymer types in MP environmental risk assessments and underscores the need of integrating multiple endpoints for a comprehensive evaluation.

RevDate: 2026-09-02

Wang Y, Zhang Y, Gao F, et al (2026)

Self-sustaining microbial reductive debromination of brominated flame retardants driven by sewage sludge-derived endogenous organics amid competing electron acceptors.

Journal of hazardous materials, 517:143412 pii:S0304-3894(26)02392-7 [Epub ahead of print].

Polybrominated diphenyl ethers (PBDEs) and tetrabromobisphenol A (TBBPA) are prevalent brominated flame retardants in wastewater and sewage sludge, yet the sustainability and robustness of their microbial reductive debromination remain poorly understood, particularly in the presence of co-existing electron acceptors (e.g., nitrate and sulfate). Here we revealed that sewage sludge-derived endogenous organic matter sustained efficient microbial reductive debromination of both TBBPA and PBDEs without external organics amendment. Over 99% TBBPA was transformed to bisphenol A within 30 days, whereas PBDE debromination occurred sequentially after TBBPA depletion, producing lower-brominated congeners (33.9%) and diphenyl ether (17.9%) after 120 days. Unexpectedly, amendment of external organic carbons (formate, acetate, pyruvate, and lactate) did not enhance debromination and instead stimulated methanogenesis, indicating diversion of electron flow towards competing reduction pathways. Reductive debromination remained highly active in the presence of 0.5-10 mM nitrate and sulfate, and similar debromination extent of both pollutants was achieved as the controls, although high nitrate and sulfate concentrations decreased TBBPA debromination rates by 42.8-67.4%. Notably, active debromination persisted even at sulfide concentrations exceeding 6 mM generated from sulfate reduction, revealing exceptional sulfide tolerance of sludge-associated organohalide-respiring bacteria (OHRB). Dehalococcoides and Dehalobacter were identified as obligate OHRB involved in debromination, with Dehalococcoides exhibiting high tolerance to nitrate-, sulfate-, and sulfide-associated stress. Moreover, the sludge microbiome was resilient and metabolically integrated despite redox perturbations. Collectively, these findings reveal sewage sludge as a self-sustaining and resilient platform for reductive debromination and provide a low-cost strategy for remediation of brominated pollutants in wastewater, sludge and other anaerobic environments.

RevDate: 2026-09-02

Spencer S, Valenzuela KN, Cheng Z, et al (2026)

Spatially controlled polymicrobial human airway model recapitulates complex interactions between Pseudomonas aeruginosa and lung commensals.

Biomedical materials (Bristol, England) [Epub ahead of print].

Airway barrier dysfunction is a hallmark of chronic lung diseases including cystic fibrosis, asthma, and chronic obstructive pulmonary disease, and is often shaped by polymicrobial rather than single-species interactions with the host tissue. However, extended host-microbe co-culture with rapid-colonizing airway pathogens such as Pseudomonas aeruginosa is difficult to sustain in accessible in vitro systems, limiting mechanistic study of polymicrobial barrier and inflammatory dynamics. Here we developed and validated an aqueous two-phase system (ATPS) that spatially confines bacterial communities over a human bronchial epithelial-endothelial transwell co-culture, extending the stable co-culture window to 24 h while preserving assayable barrier and cytokine readouts. Using a validation-by-recapitulation approach, the platform reproduced established in vivo phenomena: P. aeruginosa-driven barrier disruption, attenuation of pathogenic effects by the commensals R. mucilaginosa and L. casei with preserved junctional architecture, and S. pneumoniae exacerbation of barrier permeability accompanied by elevated IL-8 despite apparent junctional preservation. This accessible ATPS-based biomaterials platform requires no microfluidic or iPSC-derived components and provides a tractable foundation for mechanistic studies of polymicrobial interactions at the airway epithelial barrier.

RevDate: 2026-09-02

Arena L, MP Prescott (2026)

Parental Factors Associated with US Youth Ultra-Processed Food Outcomes: A Systematic Review.

Appetite pii:S0195-6663(26)00336-3 [Epub ahead of print].

Ultra-processed food (UPF) comprises 67% of the average US youth diet, among the highest rates globally. Health burdens associated with youth UPF intake include overweight/obesity, glucose dysregulation, poor cardiovascular health, liver disease, microbiome disruption, dental problems, DNA damage, mental health concerns, and lower cognitive and academic performance. This systematic review investigates parental factors associated with US youth UPF intake, preference, selection, or access. A comprehensive literature review was conducted using PRISMA guidelines. PubMed, CINAHL, Scopus, and Web of Science databases were searched. Inclusion criteria required studies to examine youth (aged 0-19) UPF outcomes and parental factors. The Mixed Methods Appraisal Tool assessed study bias and quality. PROSPERO registration number: CRD420251248701. The search yielded 1727 articles, 888 after duplicates removed. Full text review resulted in 11 extracted articles: 9 quantitative and 2 qualitative. Parental factors associated with child UPF outcomes included education level, gender (female), UPF intake, more frequent soda and fast-food intake, belief in food advertising, reward-based eating drive, allowing youth to watch greater hours of TV, and the home food environment. Mixed findings were found with parental substance use, depending on prenatal, maternal, and paternal use, cigarette, alcohol, or illicit drugs, and child age. Notable null findings included parent age, living with a partner, household income, shared family meals, human milk exposure, and parent motivation, attitude, and self-efficacy to limit junk food and eat more fruits/vegetables. Further research around parental factors and US youth UPF intake is warranted. Intervening in identified target areas may help mitigate youth UPF outcomes.

RevDate: 2026-09-02

Zhang L, Chun Y, Valeiron S, et al (2026)

Coordinated changes in oral propionate, oral microbiota, and peripheral blood inflammatory processes during peanut oral immunotherapy.

The Journal of allergy and clinical immunology pii:S0091-6749(26)00624-X [Epub ahead of print].

BACKGROUND: Peanut allergy is an increasingly prevalent condition without curative treatment. Oral immunotherapy (OIT) can induce desensitization, but its mechanisms are not fully understood. Administration of oral short-chain fatty acids (SCFAs) in murine models induces favorable immunomodulation that overlaps with processes observed in OIT. We hypothesized that in human populations, oral SCFA levels change during OIT and are associated with systemic downregulation of Type 2 processes.

METHODS: Within a clinical trial of children age 4-14 years with high-threshold peanut allergy randomized to OIT or avoidance, we profiled oral SCFA levels, the oral microbiome, and peripheral blood transcriptome over the course of OIT or avoidance. Statistical and network analyses were carried out to test our hypotheses.

RESULTS: Among the 56 children in the clinical trial with complete multi-omic profiles over the trial duration, 29 were randomized to OIT and 27 to avoidance. 100% of the participants in the OIT group achieved desensitization compared to 18.5% in the avoidance group. Oral levels of the SCFA propionate increased with OIT but not avoidance (FDR=0.042) and remained elevated with sustained unresponsiveness. Oral propionate levels positively correlated with the relative abundances of several oral microbes, including known propionate producers Prevotella spp. (r=0.47, FDR 3.75x 10-3) and Veillonella (r=0.39, FDR 1.45x10-2). Oral propionate levels negatively correlated with peripheral blood transcript expression of OIT-associated Fcγ receptors (FDR≤ 0.05), IL-4 & IL-13 signaling (FDR≤ 0.05), and neutrophil degranulation pathways (FDR≤ 0.05).

CONCLUSIONS: This study raises the intriguing possibility of oral propionate serving as an important immunoregulatory bridge between local and systemic processes in peanut OIT.

TRIAL REGISTRATION: ClinicalTrials.gov NCT03907397.

RevDate: 2026-09-02

Babenkova PI, Golovina NA, Reprintseva VN, et al (2026)

Comenic acid as a modulator of the gut-testis axis in pyridaben-induced toxicity.

Reproductive toxicology (Elmsford, N.Y.) pii:S0890-6238(26)00185-1 [Epub ahead of print].

Pyridaben is an acaricide that inhibits mitochondrial complex I, which disrupts mitochondrial viability and causes oxidative stress. Pyridaben administration was associated with significant damage to mitochondrial DNA (mtDNA) in mice. The oxidative stress related to pyridaben exposure also co-occurred with alterations in the morphology of the testes and intestines, leading to the activation of the Nrf2-dependent protective pathway in testicular tissue, reduction of the seminiferous tubule lumen accompanied by interstitial tissue swelling, and adaptive changes in the intestinal epithelial tissue. Comenic acid (CA) exhibits active antioxidant properties; in the group receiving CA, the mtDNA copy number increased. Functionally, pyridaben considerably reduced the alpha diversity of the intestinal microbiome, while CA administration appeared to normalize this indicator, also mitigating shifts in beta diversity. Taxonomic analysis revealed that pyridaben elevated the abundance of the families Bacteroidaceae and Muribaculaceae, which aligned with a functional upregulation of endotoxic dTDP-β-L-rhamnose and L-lysine biosynthesis pathways. Conversely, CA treatment attenuated these shifts, reducing opportunistic taxa while concurrently upregulating protective pathways, including folate transformations and CDP-diacylglycerol biosynthesis. These findings suggest that CA, potentially due to its antioxidant properties and modulation of the intestinal microbial and functional profiles, may exert a compensatory effect against pyridaben-induced toxicity via the gut-testis axis.

RevDate: 2026-09-02

Zhou J, Gu T, S Li (2026)

A bioinformatics framework using public 16S rRNA gene amplicon data to assess the presence of target bacteria in bat and rodent samples.

Journal of microbiological methods pii:S0167-7012(26)00296-4 [Epub ahead of print].

Validating the ecological distribution of a newly isolated bacterial species in natural hosts remains challenging due to the lack of specific detection assays and the cost of large-scale screening. Here, we describe a dual-strategy bioinformatics pipeline that leverages publicly available 16S rRNA gene amplicon sequencing data to reliably and inexpensively confirm target bacterial presence. The method first extracts hypervariable regions from the target bacterium's full-length 16S rRNA gene and evaluates their specificity by calculating an A-value-defined as the highest sequence similarity to any non-target strain in reference databases. Regions with an A-value below the 98.7% species threshold are selected. These are then aligned against Amplicon Sequence Variants (ASVs) from public datasets to compute a B-value (highest similarity to ASVs within a sample). A novel classification logic (B > A) is applied to designate samples as positive or negative, reducing false positives. The pipeline incorporates multi-level controls, including process/biological negatives and positives. Testing with novel species (Clostridium sp. nov.) and a formally described species (Streptococcus lishijunsis), along with common commensal species demonstrated that region-specific performance varies, highlighting the need for pre-validation. The framework successfully distinguished target-positive from negative samples, with phylogenetic support for specificity. This approach provides a rigorous, cost-effective, and accessible workflow that links in vitro isolation to in vivo ecological validation using existing public data.

RevDate: 2026-09-02
CmpDate: 2026-09-02

Schouten D, Wiersinga WJ, L van Vught (2026)

Post-Sepsis Syndrome: From Pathogenesis Toward Novel Management Strategies.

Critical care clinics, 42(4):745-761.

Sepsis survivorship is increasing, but many survivors develop post-sepsis syndrome, marked by high early readmission rates and new-onset conditions, notably recurrent infections, cardiovascular, psychiatric, and kidney disease. Persistent physical, cognitive, and psychological sequelae may further impair daily functioning. Emerging evidence suggests lasting immune dysregulation, likely interacting with mitochondrial dysfunction, immunosuppression, endothelial injury, low-grade inflammation, and microbiome disruption. While evidence for targeted postdischarge interventions remains limited and yields mixed results, much can still be done. Several strategies can begin during hospitalization, and after discharge a primary-care-centered, risk-stratified follow-up pathway may support recovery and reduce readmissions and complications.

RevDate: 2026-09-02
CmpDate: 2026-09-02

Morris MJ, Jaggernath KC, Martin AD, et al (2026)

The Puerperium in the Modern Dairy Cow: A Review.

Reproduction in domestic animals = Zuchthygiene, 61 Suppl 2:e70303.

The puerperium represents a critical physiological period during which the bovine reproductive tract transitions from pregnancy to renewed fertility. In the modern high-producing dairy cow, this transition is challenged by profound metabolic, endocrine, immunological, and structural demands that collectively influence uterine health, ovarian function, and subsequent reproductive performance. This review examines current understanding of the physiology of the puerperium in dairy cattle, with particular emphasis on uterine involution, immune clearance of postpartum contamination, endocrine regulation, and resumption of ovarian cyclicity. Further, it contrasts high-yielding Holsteins with fertility selected dairy populations. Normal uterine involution involves coordinated myometrial contraction, tissue remodelling, endometrial regeneration, and tightly regulated inflammatory responses. Failure of these processes predisposes cows to postpartum uterine disorders, including retained fetal membranes, metritis, endometritis (purulent vaginal discharge with cytological confirmation), and pyometra, which remain major contributors to subfertility and economic loss. Central to the pathophysiology of puerperal disease is negative energy balance, which disrupts immune competence, alters hepatic steroid metabolism, impairs ovarian signalling, and compromises oocyte and embryo quality. Emerging evidence highlights the complex interplay between metabolism, immunity, and the uterine microbiome, shifting current perspectives away from pathogen-centric models toward host resilience. Advances in biomarkers, genomic selection, and precision monitoring offer new opportunities for targeted reproductive management. Ultimately, optimisation of transition period management remains the cornerstone of supporting physiological puerperal recovery and sustaining reproductive efficiency in modern dairy systems.

LOAD NEXT 100 CITATIONS

ESP Quick Facts

ESP Origins

In the early 1990's, Robert Robbins was a faculty member at Johns Hopkins, where he directed the informatics core of GDB — the human gene-mapping database of the international human genome project. To share papers with colleagues around the world, he set up a small paper-sharing section on his personal web page. This small project evolved into The Electronic Scholarly Publishing Project.

ESP Support

In 1995, Robbins became the VP/IT of the Fred Hutchinson Cancer Research Center in Seattle, WA. Soon after arriving in Seattle, Robbins secured funding, through the ELSI component of the US Human Genome Project, to create the original ESP.ORG web site, with the formal goal of providing free, world-wide access to the literature of classical genetics.

ESP Rationale

Although the methods of molecular biology can seem almost magical to the uninitiated, the original techniques of classical genetics are readily appreciated by one and all: cross individuals that differ in some inherited trait, collect all of the progeny, score their attributes, and propose mechanisms to explain the patterns of inheritance observed.

ESP Goal

In reading the early works of classical genetics, one is drawn, almost inexorably, into ever more complex models, until molecular explanations begin to seem both necessary and natural. At that point, the tools for understanding genome research are at hand. Assisting readers reach this point was the original goal of The Electronic Scholarly Publishing Project.

ESP Usage

Usage of the site grew rapidly and has remained high. Faculty began to use the site for their assigned readings. Other on-line publishers, ranging from The New York Times to Nature referenced ESP materials in their own publications. Nobel laureates (e.g., Joshua Lederberg) regularly used the site and even wrote to suggest changes and improvements.

ESP Content

When the site began, no journals were making their early content available in digital format. As a result, ESP was obliged to digitize classic literature before it could be made available. For many important papers — such as Mendel's original paper or the first genetic map — ESP had to produce entirely new typeset versions of the works, if they were to be available in a high-quality format.

ESP Help

Early support from the DOE component of the Human Genome Project was critically important for getting the ESP project on a firm foundation. Since that funding ended (nearly 20 years ago), the project has been operated as a purely volunteer effort. Anyone wishing to assist in these efforts should send an email to Robbins.

ESP Plans

With the development of methods for adding typeset side notes to PDF files, the ESP project now plans to add annotated versions of some classical papers to its holdings. We also plan to add new reference and pedagogical material. We have already started providing regularly updated, comprehensive bibliographies to the ESP.ORG site.

Electronic Scholarly Publishing
961 Red Tail Lane
Bellingham, WA 98226

E-mail: RJR8222 @ gmail.com

Papers in Classical Genetics

The ESP began as an effort to share a handful of key papers from the early days of classical genetics. Now the collection has grown to include hundreds of papers, in full-text format.

Digital Books

Along with papers on classical genetics, ESP offers a collection of full-text digital books, including many works by Darwin and even a collection of poetry — Chicago Poems by Carl Sandburg.

Timelines

ESP now offers a large collection of user-selected side-by-side timelines (e.g., all science vs. all other categories, or arts and culture vs. world history), designed to provide a comparative context for appreciating world events.

Biographies

Biographical information about many key scientists (e.g., Walter Sutton).

Selected Bibliographies

Bibliographies on several topics of potential interest to the ESP community are automatically maintained and generated on the ESP site.

ESP Picks from Around the Web (updated 28 JUL 2024 )